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ABSTRACT
PATHOGENICITY OF MURINE CYTOMEGALOVIRUS MUTANTS
Victoria Jean Cavanaugh 
Eastern V irginia Medical School and Old Dominion University, 1995 
Director: Dr. Ann E. Campbell
Cytomegaloviruses (CMV) are species-specific DNA viruses tha t belong to 
the P-herpesvirus subfamily, and persist in  their hosts for life following prim aiy 
infection. Prim aiy infection in  the immunocompetent host is usually 
asymptomatic, however, CMV can cause severe disease and death in  the 
immunocompromised host. To better understand the pathogenic mechanisms 
of CMV infection, those viral gene products involved in  virus-host interactions 
m ust be identified. V ira l genes tha t are not required for virus replication in 
cultured cells are termed nonessential genes. It is these nonessential viral 
genes that probably encode pathogenic factors and play a critical role in  virus- 
host interactions and pathogenesis in vivo, even though they are dispensable for 
virus growth in intro. The purpose o f th is study was to identify7 nonessential 
murine CMV (MCMV) genes involved in pathogenesis in  vivo. Our approach to 
identifying these genes consisted o f constructing MCMV mutants, and then 
analyzing these m utants in vitro and in vivo. Recombinant viruses (RV) 
expressing the p-glucuronidase marker gene were constructed by site-directed 
insertion and deletion mutagenesis o f the MCMV Hind III-J and -I regions o f the 
v ira l genome. M utations were targeted to th is region o f the MCMV genome 
because the corresponding region o f the human CMV genome is nonessential
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and is involved in  down-regulating major histocom patibility complex (MHC) 
class I expression in  infected human cells. Four m utant viruses were created: 
RV5, an insertion m utant in  Hind III-J ; RV6, a deletion m utant missing 2.8 
kilobase (kb) pairs from Hind III-J ; RV7, a deletion m utant lacking 7.7 kb from 
Hind III-J  and -I; and RV9, a deletion m utant missing 10.7 kb from Hind III-J 
and -I. RV9 is a helper-dependent virus, and therefore, was not included in 
subsequent experiments. In  vitro, RV5, RV6, and RV7 grew sim ilarly to wild- 
type (WT) MCMV in  NIH3T3 fibroblasts and in  prim aiy embryo fibroblasts, 
confirm ing tha t the mutations introduced into these viruses are nonessential 
for MCMV replication in cultured fibroblasts. In IC-21 macrophages, RV5 and 
RV6 grew sim ilarly to WT virus, however, RV7 grew 2 to 3 logs lower. A one- 
step growth curve o f RV7 in  these macrophages indicated that the reduced 
growth o f th is m utant virus was prim arily due to a defect in  virus replication. 
Northern blot analyses o f immediate-early (IE), early, and late RNAs 
demonstrated tha t the block in RV7 replication occured at the IE phase of virus 
replication. A simultaneous Southern blot analysis of RV7-infected IC-21 
macrophages indicated that RV7 entered these cells as efficiently as WT MCMV. 
Therefore, poor replication o f RV7 in these cells is not the result o f a defect in 
virus entry, bu t instead is due to inadequate IE vira l gene expression. These 
data are highly significant because interactions between CMV and macrophages 
play a critica l role in  pathogenesis in  vivo, particularly in  virus dissemination 
and latency. The MCMV m utants were analyzed by Western blot w ith an 
antibody to the H-2Kb class I heavy chain to determine if  sequences w ithin Hind 
III-J  or -I were involved in the down-regulation o f MHC class I expression 
observed in  WT-infected cells. RV5, RV6, and RV7 significantly reduced the
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level o f the class I heavy chain in  infected fibroblasts, indicating that th is 
nonessential region of the MCMV genome is not involved in  class I down- 
regulation. In  infected mice, a ll o f the MCMV m utants displayed significantly 
reduced growth in  the salivaiy glands, an organ central to the biology of CMV. 
In  fact, the growth o f RV7 in  the salivary glands was barely detectable, 
indicating that the genes deleted from these viruses are required for the efficient 
replication of MCMV in  the salivary gland.
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I. INTRODUCTION
Cytomegaloviruses 
Cytomegaloviruses (CMV) are ubiquitous DNA viruses tha t infect a wide 
range o f anim al species, including humans (Staczek, 1990). These viruses 
belong to the fam ily Herpesviridae, and more specifically to the subfamily 
Betaherpesvirinae (Roizman, 1990a). Characteristics o f the members o f th is 
subfamily include: s tric t species specificity, a relatively long replication cycle, 
and a slowly developing cytopathology characterized by cytomegaly, or an 
enlargement o f the infected cell. In  human and other animal populations, the 
incidence o f infection w ith  CMV can approach 100% (Alford and B ritt, 1990).
In healthy individuals, CMV is nonpathogenic, and primary infection is not 
accompanied by apparent disease. Following primary infection, CMV persists in 
its  host for life, manifested as asymptomatic productive infection or viral 
latency. CMV reveals its  pathogenic capabilities in  the immunocompromised 
host. The virus can cause severe disease, and even death, in  those individuals 
w ith immature immune systems, such as the fetus and newborn, or in  those 
w ith  suppressed immune systems, such as patients w ith AIDS or those 
receiving immunosuppressive treatments for either cancer or organ 
transplantation.
H istorical Perspective 
Infection w ith CMV characteristically produces cytomegaly w ith 
intranuclear inclusions (Staczek, 1990). H istorically (historical accounts
1
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reviewed in  Alford and B ritt, 1990 and Staczek, 1990), one of the earliest 
reports describing th is cytopathology was published in 1904 by Jesionek and 
Kiolemenoglou who examined several organs o f a newborn infant thought to 
have died o f syphilis. S im ilar reports o f these cytomegalic cells observed in the 
tissues o f other patients w ith  fatal infection led to the early designation o f 
“cytomegalic inclusion disease”, or CID, even before the causative agent was 
identified. Many early investigators believed th a t the intranuclear inclusions 
were the result o f parasitic or protozoan infections. A vira l etiology for CID was 
firs t proposed in  1921 by Lipschutz, who recognized that sim ilar inclusions 
were also observed in  herpetic lesions. In  the same year, Goodpasture and 
Talbot reported the sim ilarity of cytomegalic cells found in  the parotid glands of 
infants studied a t autopsy to those found in the parotid glands of guinea pigs. 
In  1926, Cole and Kuttner provided the firs t experimental evidence tha t the 
causative agent o f CID was a virus. Using a guinea pig model, they showed 
tha t filtered homogenates o f inclusion-bearing salivary glands from adult 
animals were infectious for inclusion-free younger animals. They also 
demonstrated th a t the infectious agent was species specific. Because the 
disease, in  both animals and humans, was associated w ith infection o f the 
salivary glands, the causative agent was termed “salivary gland virus” .
In 1954, Sm ith succeeded in  isolating and propagating the mouse 
salivary gland virus in  mouse embryonic fibroblasts (Smith, 1954). Two years 
later, the human virus was isolated independently by three different 
investigators (reviewed in  Alford and B ritt, 1990). Smith isolated the virus from 
the salivary gland o f an infant dying o f generalized CID. Rowe and his
2
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coworkers isolated three strains o f the human virus from the adenoidal tissue of 
children who underwent tonsil and adenoidectomies. Strain AD 169, a 
commonly used laboratoiy adapted strain, originated from these studies. And 
Weller and colleagues recovered the human virus from the urine of a living 
in fant w ith generalized CID (Weller et. al., 1957). I t  was Weller who coined the 
term “cytomegalovirus” to describe the cellular changes produced by these 
viruses.
V irion Structure
The virion structure of CMV, like tha t o f a ll herpesviruses, consists o f:
1) an inner core, containing the linear, double-stranded DNA genome complexed 
helically w ith protein, 2) a capsid enclosing the genome and consisting of a to ta l 
o f 162 protein capsomere subunits arranged in  an icosadeltahedral shape (20 
surfaces), 3) a tegument, or amorphous material surrounding the capsid, and 4) 
an envelope, or outer covering, derived from patches o f cellular membrane 
containing vira l glycoprotein spikes (Roizman, 1990a). The virions are 
pleomorphic and have a diameter o f between 150 and 300 nanometers, due to 
variability in  the thickness of the tegument (Griffiths and Grundy, 1987).
V ira l Genome
CMV has the largest and most complex genome o f any known virus 
(Stinski, 1990). The genomes o f both human CMV (HCMV) and murine CMV 
(MCMV) are approximately 230 kilobase pairs in  length, and are estimated to 
encode over 200 genes (Chee et. al., 1990; Rawlinson et. al., 1993).
The genomic structure o f animal CMVs vary according to the presence 
or absence o f term inal and internal reiterated sequences (Roizman, 1990a). For
3
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example, in  the HCMV genome, sequences from both term ini are repeated in  an 
inverted orientation and juxtaposed internally, dividing the genome into two 
unique components, each flanked by inverted repeats (Stinski, 1990) (shown in 
Fig. 1). The unique components, termed the unique long (Ul) and the unique 
short (Us) regions, can invert relative to each other during virus replication, 
giving rise to four genomic isomers. V irions can contain any one o f these four 
isomers, and viral DNA extracted from infected cells or virions consists of 
equimolar concentrations o f a ll four isomers. In  contrast, the MCMV genome 
consists prim arily o f unique sequences w ith  no repeat sequences, and therefore 
does not isomerize (see Fig. 1).
V iral Replication
Infection of cells by CMV does not guarantee tha t viral m ultiplication w ill 
occur, or tha t viral progeny w ill be produced. Infection w ith CMV can be 
productive, abortive, restrictive, or latent (reviewed in  Roizman, 1990b). A 
productive infection occurs in  permissive cells, and results in  the production of 
infectious progeny. An abortive infection can occur in  nonpermissive cells, in  
which case some, bu t not a ll, virus genes are expressed; or can result from 
infection w ith  defective viruses, which lack viral genes required for progeny 
production. A restrictive infection can occur in  a transiently permissive cell, 
resulting in  virus persistence inside the cell un til the cell becomes permissive, 
or in only a few' cells in  a population producing vira l progeny at any one time. 
And lastly, a latent infection occurs when the viral genome is maintained inside 
the cell w ithout the production o f any infectious virus particles.
4
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The general pattern of CMV replication in  a fu lly  permissive cell is as 
follows (reviewed in  Stinski, 1990). Infection is initiated when the virus 
attaches to receptors on the surface o f the cell. Penetration occurs almost 
instantaneously after attachment, and involves fusion o f the cellular membrane 
w ith the virion envelope. The attachment and penetration phases o f CMV 
infection are complex, and require the coordinated participation o f m ultiple 
cellular and vira l components. The in itia l event in  HCMV infection is 
attachment o f the virion to extracellular heparin sulfate proteoglycans 
(Compton et. al., 1993). This in itia l interaction is absolutely required for virus 
infection, and involves several vira l envelope proteins, including the glycoprotein 
B (gB). The binding o f envelope glycoproteins to cell surface heparin sulfate 
then facilitates high affin ity binding to a cellular receptor(s). HCMV specifically 
binds to 32- and 34-kilodalton (kd) membrane glycoproteins present on the 
surface of a variety of cell types, including cells o f endothelial, epithelial, 
fibroblastic, and monocytoid origins (Cooper et al., 1991; Nowlin et al., 1991).
In addition, an interaction between the HCMV glycoprotein H (gH) and a 92.5 
kd cellular protein is believed to play a role in virus penetration (Keay and 
Baldwin, 1991). Following penetration, the envelope o f the virus remains in  the 
plasma membrane o f the infected cell, and the internal contents o f the virion 
spill into the cytoplasm.
The de-enveloped capsid is then transported along the cytoskeleton to 
the nuclear pores, where the viral DNA is released into the nucleus and 
immediately circularizes (Roizman, 1990b). However, it  is unclear i f  or how the 
MCMV genome circularizes, since it lacks term inal repeat sequences which are
5
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involved in  circularization. The vira l genomes are transcribed and replicated in  
the nucleus, and the transcriptional enzymes o f the host cell are used to 
generate viral mRNA. The synthesis of vira l gene products is temporally 
regulated and sequentially ordered. V iral gene expression is divided into three 
general kinetic classes: immediate early (IE), early (E), and late (L) (reviewed in 
Stinski, 1990).
The IE genes are the firs t to be expressed following CMV infection, and 
require no prio r v ira l protein synthesis. Cis-acting DNA elements in the 
promoters o f the IE vira l genes enable the binding o f cellular transcription 
factors for the in itia tion  of IE transcription. In both HCMV and MCMV, the 
promoters of the major IE gene region contain an unusually strong and complex 
enhancer (Dorsch-Hasler et al., 1985; Thomsen e ta l., 1984). This IE enhancer 
consists of highly conserved sets o f repeated sequence m otifs which contain 
binding sites for cellular transcription factors, including NF-kB, ATF, and AP-1, 
and provides a very strong entry site for the cellular RNA polymerase II and 
other components of the transcriptional machinery (Ghazal et al., 1987; 
Mocarski et al., 1990). In  the case o f herpes simplex virus (HSV), a virion 
tegument protein (VP 16), introduced into the cell following penetration, trans- 
activates the IE vira l genes by acting in concert w ith  host factors (Roizman, 
1990b). HCMV also contains a virion-associated transactivator, the pp71 
tegument protein encoded by the UL82 gene (Liu and Stinski, 1992). This 
protein stimulates transcription from viral and cellular promoters containing 
upstream ATF sites, and enhances transcription from the major IE. promoters of 
both HCMV and MCMV by as much as 20-fold. Following immediate early
6
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
transcription, the CMV mRNAs are transported into the cytoplasm and are 
translated. The IE proteins are then transported back into the nucleus where 
they function to stim ulate and regulate subsequent vira l gene expression.
In both HCMV and MCMV, the major IE promoter drives the expression 
o f prim arily two regions, referred to as IE1 and IE2 in  HCMV (Stenberg et al., 
1985; Stinski et al., 1983), and IE1 and IE3 in MCMV (Keil et al., 1987). The 
most abundantly expressed IE gene in  both viruses is the IE1 gene, which 
encodes a protein w ith  a molecular weight o f 72 kd in  HCMV (IE72) (Stenberg et 
al., 1984) and 89 kd in  MCMV (pp89) (Keil et al., 1985). Both IE1 gene 
products are phosphoiylated nuclear proteins w ith  a high percentage o f acidic 
residues, and both function to transactivate cellular and vira l promoters 
(Koszinowski et al., 1986; Stenberg et al., 1990). Remarkably though, there is 
very' little  homology between IE72 and pp89 in either nucleic acid or amino acid 
sequences (Mocarski et al., 1990). Unlike its  counterpart in  HCMV, pp89 of 
MCMV can bind directly to DNA, mediated by its interactions w ith core histone 
proteins (Munch et al., 1991 and 1992). Interestingly, a single 9-amino-acid 
immunodominant epitope from pp89 induces a cytotoxic T lymphocyte (CTL) 
response in BALB/c mice that protects against lethal MCMV challenge (Del Val 
et al., 1991). Downstream o f the IE1 gene in  HCMV is the IE2 gene, which 
encodes another regulatory protein w ith a molecular weight of 86 kd, and is 
designated IE86 (Stenberg et al., 1989). Its MCMV counterpart, designated IE3, 
has a molecular weight of 88-90 kd, and shows strik ing homology to the IE86 
protein in  both its  amino acid sequence and its  regulatory functions (Messerle 
et al., 1992). Both proteins represent strong transcriptional activators o f v ira l
7
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and cellular promoters, and show an autoregulatoiy function by repressing the 
major IE promoter. In HCMV, IE72 and IE86 interact synergistically to 
transactivate early vira l promoters (Malone et al., 1990; Stenberg et al., 1989 
and 1990). In MCMV, the IE1 and IE3 proteins act together to transactivate 
early vira l gene expression (Buhler et al., 1990). The mRNAs encoding IE72 and 
IE86 o f HCMV, as well as the mRNAs encoding the IE1 and IE3 proteins of 
MCMV, arise by alternative splicing. The MCMV IE2 gene represents a 
divergence from th is organization, and has no known counterpart in  HCMV. 
This MCMV gene is located at the other side of the enhancer sequence, and is 
transcribed in the opposite direction (Messerle et al., 1991). The MCMV IE2 
gene product has no role in  transcriptional activation, nor is it  needed for virus 
replication in  murine NIH3T3 fibroblasts (Manning and Mocarski, 1988).
The early phase of vira l gene expression follows the immediate early 
phase (reviewed in Stinski, 1990). Many E gene products are enzymes and 
DNA-binding proteins involved in  vira l DNA replication, and include the DNA 
polymerase, the polymerase-associated protein, the major-DNA-binding protein 
(MDBP), and three subunits o f a helicase-primase complex (Pari and Anders, 
1993). In HCMV, eleven loci are required for vira l DNA replication (Pari and 
Anders, 1993). Six o f these loci encode the proteins listed above, which are 
essential to initiate and perform DNA synthesis. The remaining five loci encode 
regulatory proteins required to express these factors from the ir native 
promoters, and include the IE1 /IE 2  loci. The DNA polymerases and MDBPs 
from HCMV and MCMV show strik ing sim ilarity in  amino acid sequence, 72% 
homology for the MDBP and 73% homology for the polymerase (Messerle et al.,
8
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1992). This conservation points to the essential functions o f these proteins in  
the replication o f the vira l DNA. The MDBP binds to and stabilizes the single­
stranded DNA immediately after unwinding o f the double helix, and facilitates 
the entiy o f the vira l DNA polymerase and subsequent vira l DNA replication (Wu 
et al., 1988). The vira l DNA polymerase is distinguished from the host enzyme 
by its requirement for high salt concentrations, its  sedimentation properties, 
and its reversible inh ib ition  by phosphonoacetic acid (G riffiths and Grundy, 
1987). During the early phase o f infection, the vira l DNA is replicated by a 
rolling circle mechanism that yeilds head-to-tail concatemers of unit-length 
vira l DNA. Because th is mechanism o f DNA replication involves the term inal 
repeat sequences o f the v ira l genome, it is not known whether the MCMV 
genome is replicated by th is method.
The last round o f transcription and translation produces the L proteins, 
which largely represent the structural proteins o f the virion (reviewed in  Stinski, 
1990). These structura l proteins include those of the capsid, the envelope, and 
the tegument, a fibrous and granular material interfaced between the capsid 
and the envelope. M atrix proteins represent part o f the tegument and function 
to anchor the envelope to the capsid. The HCMV virion contains several m atrix- 
tegument proteins, a ll o f which are phosphoproteins (pp) and are designated by 
their molecular weights. These m atrix proteins include pp28, pp64, pp65, 
pp71, and pp l50. In contrast to MCMV immunobiology, the immunodominant 
CTL epitopes o f HCMV are directed predominantly against determinants w ith in  
these matrix-tegument proteins, particularly pp65 and pp l50  (Greenberg,
1995). The pp65 m atrix protein also elicits a strong humoral immune response,
9
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probably because th is protein is the most abundant virus-encoded protein, 
comprising more than 50% o f the mass o f the virion (Landini et al., 1988). The 
major and m inor capsid proteins o f HCMV have molecular weights o f 150 and 
36-40 kd, respectively. Both the HCMV and MCMV genomes encode a highly 
conserved L gene, referred to as the ICP18.5 homolog, which functions in  virus 
assembly (Addison et al., 1990; Messerle et al., 1992).
The vira l envelope comprises a lip id  bilayer membrane containing virally- 
encoded glycoproteins. Three o f these glycoproteins, B (gB), H (gH), and L (gL), 
are conserved in  amino acid sequence and te rtia iy structure among a ll 
herpesviruses (Stinski, 1990; Xu et al., 1994). These glycoproteins are believed 
to play critica l roles in  virus attachment, membrane fusion events and entry, 
and cell-to-cell spread (Rapp et al., 1992 and 1994). In  addition, a high 
proportion of neutralizing antibodies, in  both human and mouse antisera, are 
directed against these glycoproteins (B ritt et al., 1990; Rapp et al., 1994; Xu et 
al., 1994). In  both hosts, anti-gH serum neutralizes v ira l infectivity in the 
absence of complement (Rapp et al., 1994; Rasmussen et al., 1984).
During the late phase o f CMV infection, the nucleocapsid proteins 
assemble in  the nucleus to form empty capsids (reviewed in Roizman, 1990b). 
V iral DNA is then cleaved from concatamers and is packaged into the capsids. 
And lastly, the envelopment and m aturation o f the virions occur at the inner 
lamella of the nuclear membrane. The virus acquires infectivity by budding 
through th is membrane, and enveloped virions accumulate in  the space 
between the inner and outer lamellae o f the nuclear membrane.
10
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During MCMV replication, the immediate early phase represents the firs t 
two to three hours o f infection, the early phase occurs between three to sixteen 
hours after infection, and the late phase begins at approximately sixteen hours 
post-infection (Mocarski et al., 1990). Infectious vira l progeny are produced 
soon after the late phase o f virus replication begins, a t approximately eighteen 
to twenty hours following infection.
V iral Pathogenesis 
Cytomegaloviruses are species-specific viruses w ith respect to replication 
and pathogenesis (Mocarski et al., 1990). In  addition, only differentiated cells 
appear to be fu lly  permissive. Infection o f permissive cells w ith CMV is 
characterized by cytomegaly, nuclear swelling, chromatin margination, and the 
formation o f intranuclear and intracytoplasm ic inclusions (Staczek, 1990). In a 
productive infection, CMV is usually cytolytic and eventually destroys the cell in 
which it  replicates.
In normal, healthy individuals, CMV is nonpathogenic and prim aiy 
infection, which usually occurs during early childhood, causes little  or no overt 
illness (reviewed in Alford and B ritt, 1990). Most CMV infections are 
asymptomatic because the virus has evolved to live in  equilibrium  w ith its host. 
Antivira l immune defenses function to control CMV infection (see below), and 
when host immune functions are intact, virus replication and spread are 
restricted. However, even the immunocompetent host fails to eradicate CMV 
following prim aiy infection. Like a ll herpesviruses, CMV remains associated 
w ith the infected individual for life, manifested either as asymptomatic 
productive infection or vira l latency. During latency, the virus remains in a
11
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quiescent state, bu t can be reactivated to produce recurrent infections. 
Reactivation o f latent virus is detected following immunosuppression or 
immunodeficiency, because the host immune response is unable to contain the 
recurrent infection.
The outcome o f acute CMV infection depends on the age and immune 
status o f the host (reviewed in  Alford and B ritt, 1990 and Mocarski et al., 1990). 
CMV can cause life-threatening illnesses in  those w ith  immature or suppressed 
immune systems. When im m unity is compromised, the virus represents an 
opportunistic pathogen tha t is permitted to replicate unrestricted to produce 
severe or lethal disseminated disease. Individuals at high risk for CMV disease 
include the very young, such as the developing fetus or newborn, patients 
undergoing immunosuppressive therapy for either cancer or organ 
transplantation, and those w ith progressive immunodeficiency diseases, such 
as AIDS.
CMV can cross the placenta and infect the immunologically immature 
fetus (reviewed in Alford and B ritt, 1990). In  utero transmission can result from 
either primary or reactivated maternal infections, and the incidence of 
congenital CMV infection is high in  comparison to other intrauterine viral 
infections. Approximately 1% o f infants bom in  the United States each year are 
congenitally infected w ith  CMV. O f these infants, approximately 10% show 
moderate to severe symptoms, and 90% display subclinical infection. The 
clinical manifestations o f congenital CMV infection include permanent brain 
damage, mental retardation, hepatic disease and jaundice, pneumonia, 
deafness, and ocular abnormalities. Severe disseminated disease in the
12
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newborn is often fatal, and is characterized by widespread central nervous 
system (CNS) damage and frequent occurrences o f microcephaly. Those infants 
bom w ith less severe disseminated infections usually develop significant CNS 
defects in  the firs t two years o f life. Congenital CMV infections are second only 
to Down’s Syndrome as a known cause o f mental retardation. Infants w ith 
subclinical infections commonly exhibit hearing loss and ocular abnormalities, 
including chorioretinitis and optic atrophy.
In  immunocompromised patients, reactivation o f virus from latency 
represents a major cause o f m orbidity and m ortality (reviewed in Alford and 
B ritt, 1990). CMV is the most frequent vira l pathogen following organ 
transplantation, and recurrent infection occurs in  approximately 85% o f renal 
and cardiac allograft recipients. The clin ical manifestations in transplant 
patients include in te rstitia l pneumonia, hepatitis, gastrointestinal hemorrhage 
and ulceration, and re tin itis  (Ho, 1991). CMV pneumonitis is one of the major 
causes o f death in  leukemia patients receiving bone marrow transplants, and 
its  m ortality rate in  these individuals is 84% (Ho, 1991).
CMV is also one o f the most common opportunistic pathogens in AIDS 
patients, and represents a major cause o f morbidity, and often the cause of 
death, in  these individuals (reviewed in  Nelson et al., 1990). The diseases 
caused by CMV in  patients w ith  AIDS include encephalitis, retinitis, 
pneumonia, adrenalitis, hepatitis, and colitis. In  these patients, HCMV is 
believed to act as a co-factor which accelerates the progression o f AIDS 
pathogenesis. Actually, molecular interactions between HIV and HCMV occur 
in  both directions: the HIV long term inal repeat is transcriptionally activated by
13
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the major IE proteins o f HCMV, and HCMV replication is enhanced by the 
presence o f active HIV infection (Fiala et al., 1991; Nelson et al., 1990). This 
synergistic role of CMV w ith  HIV is most evident in  the brains of AIDS patients. 
HCMV is present in  the brains o f approximately one-third of AIDS patients 
(studied at autopsy), where it  infects capillary endothelial cells, m icroglial cells 
(brain macrophages), and neurons (Wiley and Nelson, 1988). In these 
individuals, coinfection o f the brain w ith  HIV and HCMV induces a more severe 
form o f dementia (called AIDS-dementia complex complicated by CMV 
encephalopathy, or ACE) (Fiala et al., 1991).
In the immunocompetent host, acute infection w ith  CMV leads to the 
productive infection o f most organs, including the following: salivary glands, 
spleen, liver, lungs, kidneys, adrenal glands, pancreas, brain, ovaries, testes, 
lymph nodes, bone marrow, placenta, eye, and skin (reviewed in Mocarski et al., 
1990). In vivo, CMV characteristically infects epithelial cells in  these organs, 
and seldomly involves fibroblasts, which is in  stark contrast to its growth in  cell 
culture. During infection, virus produced in the salivary glands, kidneys, and 
mammary tissues can be excreted in saliva, urine, and m ilk (respectively) for 
extensive periods o f time. Horizontal transm ission (extrauterine) of CMV results 
from direct contact w ith  these contaminated bodily secretions (reviewed in 
Alford and B ritt, 1990). The dominant routes of transm ission during childhood 
appear to be oral and respiratory, resulting from contact w ith saliva or the 
inhalation or ingestion o f infected material. Additionally, CMV is present in  
semen and cervical and vaginal secretions, and is spread sexually during
14
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puberty and adulthood. CMV can also be spread by blood transfusion or organ 
transplantation from sero-positive donors to sero-negative recipients.
Salivary gland involvement is a hallm ark o f CMV infection (reviewed in  
Mocarski et al., 1990). The virus displays a well-established tropism  for the 
salivary gland, which remains persistently infected for long periods o f time 
following infection. As a result, oral secretions represent a primary source of 
high-titered virus, and shedding from th is  tissue is the principle means by 
which the virus is spread w ith in  a population. In  the human, the parotid 
salivary gland is most frequently involved, w ith  virus replication occuring 
predominantly in  the ductal epithelium  (Alford and B ritt, 1990). In  the mouse, 
the subm axillaiy salivary gland represents the prim ary site o f MCMV 
replication, w ith in  the serous acinar epithelial cells (Mims and Gould, 1979). 
MCMV grows to its  highest titers in  vivo in  the salivary glands, and virus 
produced in  th is organ is significantly more viru lent than that produced in any 
other organ or in  cell culture (Selgrade et al., 1981).
Murine Model o f MCMV Pathogenesis
S trict species-specificity of CMV has prevented the study o f HCMV in  any 
animal model. However, infection o f mice w ith  MCMV has been extensively 
used as a model for analysis o f CMV pathogenesis (Staczek, 1990). The human 
and murine viruses share the following characteristics: a large DNA genome of 
approximately 230 kilobase pairs in  length, analogous gene products w ith  
sim ilar functions, and biologically sim ilar aspects o f pathogenesis, tissue 
tropism, latency, and reactivation (Mocarski et al., 1990).
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The pathogenicity o f experimental MCMV infections depends upon 
m ultiple factors, including: the strain, age, and immune status o f the animal; 
as well as, the passage history o f the virus, and its  dose and route o f 
inoculation (reviewed in  Mocarski et al., 1990). Inbred mouse strains differ in 
the ir susceptibilities to MCMV infection, which is partially determined by the 
genes o f the major histocom patibility complex (MHC), also termed H-2 genes in 
mice. Mouse strains o f the H-2k haplotype, such as the C3H and CBA strains, 
are more resistant to MCMV infection. In  contrast, strains of the H-2d and H- 
2b haplotypes, such as BALB/c and C57BL/6 mice, respectively, are 
susceptible to MCMV disease. The resistance o f inbred mouse strains to lethal 
MCMV infection is the result o f m ultiple factors determined by both H-2 and 
non-H-2 genes (Mercer and Spector, 1986; Scalzo et al., 1990). For example, 
the resistance of various strains correlates well w ith  the magnitude of their 
immune defense mechanisms, such as interferon production, natural k ille r cell 
activity, and CTL-mediated responses (reviewed in  Mercer and Spector, 1986). 
In addition, resistance is partia lly conferred by the crrw-1 allele, which restricts 
the level o f MCMV replication in  the spleen, a major site o f early virus 
replication in vivo (Scalzo et al., 1990).
In  newborn mice, relatively low doses of virus produce rapidly lethal 
effects (Staczek, 1990). However, as the animal matures, increasingly higher 
doses o f virus are necessaiy to produce disease and death. The virus is 
especially virulent for mice that are less than three weeks o f age. Apparently, 
the fourth  week of life represents a period of rapid change in MCMV 
pathogenicity. MCMV infection is more severe and can be initiated w ith
16
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significantly lower doses o f virus in  immunosuppressed mice, such as tha t 
induced by tota l body y-irradiation (Reddehase et al., 1985), or in  genetically 
immunodeficient mice, such as those w ith Severe Combined Immunodeficiency 
(SCID mice) (Pollack and V irgin, 1995). For example, in  BALB/c weanling mice 
a t three weeks o f age, 10s plaque-forming units (PFU) o f virus w ill k ill one-half 
o f the animals inoculated (called the 50% lethal dose, or LDso) (Katzenstein et 
al., 1983), whereas a SCID mouse w ill succumb to as little  as two to three PFU 
o f virus (Pollack and Virgin, 1995).
MCMV derived from the salivary glands o f infected mice is significantly 
more virulent than that produced in  any other organ or in  cell culture (Jordan 
and Takagi, 1983; Selgrade et al., 1981). For example, the LDso for salivaiy- 
gland-passaged MCMV in  one-week-old suckling BALB/c mice is 30 PFU, 
whereas for tissue-culture-passaged virus it  is 450 PFU (Sammons and Sweet,
1989). V irulent salivaiy-gland-passaged MCMV is rapidly attenuated by a 
single passage in  cell culture (Osborn and Walker, 1970), however, th is 
attenuation can be reversed again by passage in  the mouse. The mechanism of 
th is dramatic modification is not clear, but is presumed to be epigenetic.
MCMV grown in  tissue culture consists prim arily o f multicapsid virions, 
enveloped particles which contain from 2 to 20 capsids (Chong and Mims,
1981; Weiland et al., 1986). In contrast, salivary-gland-passaged MCMV 
consists of predominantly single capsid enveloped virions. During MCMV 
morphogenesis in  cultured fibroblasts, assembled capsids exit the nucleus 
through the nuclear pores, and form cytoplasmic inclusions consisting of 
capsid aggregates (Weiland et al., 1986). These capsid aggregates then bud into
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extended cytoplasmic vacuoles derived from the Golgi apparatus, forming 
m ulticapsid virions. On the other hand, monocapsid virions are generated by 
budding at the inner nuclear membrane. Multicapsid virions, characteristic of 
in  vitro-propagated MCMV, may be less virulent in  vivo because they are fragile 
and are rapidly lysed in  extracellular fluids (Chong and Mims, 1981). 
Alternatively, since monocapsid and multicapsid virions acquire their envelopes 
at different intracellu lar sites, the compositions o f their envelopes may be quite 
different, resulting in  different properties during the infection process (Weiland 
et al., 1986). In  addition, salivary-gland-passaged MCMV is coated w ith non­
neutralizing antibody, and may exhibit different adsorption properties in vivo 
(Chong e ta l., 1981).
Following acute infection o f susceptible mice, the spleen and the liver 
represent prim ary sites of early virus replication, and virus titers in  these 
organs peak by the th ird  day after inoculation (by either intraperitoneal or 
intravenous routes) (Katzenstein et al., 1983; Yuhasz et al., 1994). Early 
replication o f virus in  the spleen contributes significantly to the pathogenesis o f 
MCMV infection (Katzenstein et al., 1983). Splenectomized mice survive acute 
MCMV infection in  significantly greater numbers than mice w ith  spleens, and 
virus titers in  the livers of splenectomized mice are lower. A ll other organs o f 
the infected animal represent secondary sites o f virus replication, and become 
infected following virus dissemination via the blood (Stoddart et al., 1994).
In the lung, virus titers peak by the tenth or eleventh day following 
infection (Yuhasz et al., 1994). Using the polymerase chain reaction on reverse 
transcribed RNA samples from the lungs of infected mice, MCMV IE1 RNA is
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present in  lung tissue fo r up to 4 months following infection (Yuhasz et al., 
1994). In  addition, after the acute phase o f infection, the number o f MCMV 
genome equivalents in  the lung is 10-fold higher than in  any other organ 
(Balthesen et al., 1993; Yuhasz et al., 1994). MCMV infection in  the lung is 
fundamentally different than in  other organs, and a low-level chronic infection 
occurs in the lung for a t least 4 months following infection. The significantly 
higher level o f recurrent infection in  the lungs o f irradiated mice (Balthesen et 
al., 1993) is probably attributable to the presence o f an active vira l infection in  
th is  organ. When the host becomes immunosuppressed, th is low-level chronic 
infection increases in  activity and leads to clin ically apparent disease. This may 
explain the high incidences of CMV-induced pneumonia in  organ transplant 
recipients and patients w ith  AIDS (Ho, 1991; Nelson et al., 1990).
In the salivary glands o f inoculated mice, MCMV tite rs peak by thirteen 
to fourteen days post-infection (Mims and Gould, 1979). The visceral organs of 
infected animals (excluding the lung) are usually cleared o f virus by four weeks 
after infection, largely as the result o f an aggressive CTL immune response 
(reviewed in  Koszinowski et al., 1990). However, high levels o f virus continue to 
be produced in the salivary glands for over one month, and clearance from this 
organ usually occurs by the sixth or seventh week following inoculation (Jonjic 
et al., 1989). Remarkably, CD8+ T lymphocytes are unable to clear MCMV 
from the salivary gland, instead CD4+ T cells are essential for the clearance of 
th is tissue (Jonjic et al., 1990). The CD4+ T lymphocytes involved belong to 
the T h l subset, and the antiv ira l activity of these cells is dependent on gamma 
interferon (IFN-y) (Lucin et al., 1992). However, recombinant IFN-y cannot
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replace the function o f T h l cells, indicating that there are other essential 
factors involved in  salivaiy ^land clearance.
MCMV establishes a latent infection in  the spleen, kidney, lung, salivaiy 
gland, bone marrow, and blood (reviewed in  Mocarski et al., 1990). Latency is 
defined as the maintainance of vira l genomic DNA, w ith  the absence of 
infectious virus production (Roizman, 1990b). In the mouse, reactivation of 
latent MCMV is detected following immunosuppression. Typically, 
immunosuppression is induced by sublethal total-body irradiation (Mutter et 
al., 1988) or by treatment w ith  anti-CD4 and anti-CD8 antibodies (Cardin et al., 
1993), both o f which cause a profound immunodepletion. In vitro, virus 
reactivation is detected by explant cocultivation, in  which organs are removed 
from latently infected mice, minced, and cultured w ith  permissive cells for two 
to three weeks (Jordan and Pomeroy, 1991). Latency is distinguished from 
persistence, or the low-level production o f infectious virus (such as tha t which 
occurs in  the lungs and salivary glands), by sensitive assays designed to detect 
veiy low levels o f infectious MCMV in tissues of infected animals. These assays 
include: PCR analysis of reverse-transcribed RNA isolated from tissues (Yuhasz 
et al., 1994), prolonged in vitro culture o f organ homogenates on permissive cell 
monolayers, and inoculation of SCID mice w ith organ homogenates (Pollack and 
Virgin, 1995).
Using these methods, the organs harboring latent MCMV have been 
identified, however the precise identification of the latently infected cell type(s) 
remains obscure. In  the spleen, latent MCMV is harbored w ithin the stromal 
fraction, a ductal network o f sinuses supported by reticulum  cells, fibroblasts,
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numerous macrophages, endothelial cells, sinusiodal-lining cells, and collagen 
fibers (Pomeroy et al., 1991). In  both the human and the mouse, monocytes 
and macrophages are strongly suspected as being a reservior o f latent CMV 
(Brautigam et al., 1979; Jordan and Mar, 1982; Kondo et al., 1994).
Role o f Mononuclear Cells in CMV Pathogenesis 
Another hallm ark o f acute CMV infection is a leukocyte-associated 
viremia (Bale and O’Neil, 1989; Collins et al., 1994; Dankner et al., 1990; 
Saltzman et al., 1988; Stoddart et al., 1994). In  both humans and mice, CMV 
can be recovered from peripheral blood leukocytes o f individuals w ith acute 
infection, although the percentage o f cells supporting productive infection is 
quite small. In CMV viremia, monocytes are the predominant infected leukocyte 
cell type, and serve as the vehicle o f virus dissemination during infection 
(Collins et al., 1994; Stoddart et al., 1994; Taylor-Wiedeman et al., 1991). In 
mice intraperitoneally inoculated w ith  MCMV, th is mononuclear viremia enables 
virus dissemination from in itia l sites o f replication in  the peritoneum, spleen, 
and liver to secondary sites, such as the salivary gland and lung (Collins et al., 
1994; Stoddart et al., 1994). In  these mice, viremia peaks on the sixth day 
following infection, at which time it  is estimated tha t MCMV DNA is present in 
up to 0.1% of circulating leukocytes (Bale and O’Neil, 1989). The viremia in 
mice is actually biphasic: a primary viremia occurs on day two post-infection; 
these infected leukocytes, predominantly mononuclear, disseminate MCMV to 
the spleen and liver; the virus then replicates and is released from cells w ith in  
these organs, resulting in  a more intense secondary viremia on day six following 
infection (Collins et al., 1994). Although MCMV DNA can be detected in both
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mononuclear and polymorphonuclear leukoctyes during viremia, infectious 
virus can be recovered only from the monocuclear fractions o f circulating 
leukocytes (Collins et al., 1994; Stoddart et al., 1994).
In both humans and mice, monocytes and macrophages have been 
implicated as the most likely cell type harboring latent CMV (Brautigam et al., 
1979; Kondo et al., 1994; Stoddart et al., 1994; Taylor-Wiedeman et al., 1991). 
Sensitive PCR methods have reproducibly demonstrated the presence o f HCMV 
DNA in  peripheral blood monocytes o f healthy seropositive individuals (Taylor- 
Wiedeman et al., 1991). In vitro, human granulocyte-macrophage progenitors 
(derived from fetal liver and bone marrow) can be latently infected w ith HCMV, 
and 4 weeks later, virus can be reactivated after prolonged cocultivation w ith  
permissive cells (Kondo et al., 1994). Reactivation o f latent HCMV in  these cells 
is dependent upon cellular differentiation tha t occurs during cocultivation. 
HCMV permissiveness in prim aiy monocytes derived from the blood of 
seronegative donors is also dependent on morphological differentiation into 
macrophages (Ibanez et al., 1991). Cellular activation and differentiation are 
prerequisites for CMV expression and permissiveness in th is cell type, as well as 
in others (Mocarski et al., 1990).
In murine models of acute infection, monocytes have been clearly shown 
to contain MCMV DNA, to release infectious virus, and to be the primary vehicle 
for virus dissemination (Collins et al., 1994; Stoddart et al., 1994). In  addition, 
in  latently infected mice, macrophages harvested from the peritoneal cavity were 
found to contain MCMV DNA and to produce infectious virus upon in vitro 
stim ulation w ith  thioglycollate (Brautigam et al., 1979). Permissiveness o f
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murine macrophages for MCMV infection depends upon the differentiation state 
o f the cell (Lewis et al., 1990). For example, an undifferentiated macrophage 
cell line (P388D1) is nonpermissive for MCMV replication, whereas a partially 
differentiated cell line (J774A. 1) is  semipermissive and a fu lly  differentiated cell 
line (IC-21) is permissive. MCMV infection o f J774A.1 macrophages enhances 
the secretion of biologically active IL -la  and J3, indicating th a t the virus may 
influence immune functions by altering the levels o f monokines (Lewis et al., 
1990). In  addition, the HCMV IE1 gene enhances expression from the human 
IL -1(3 promoter in  transient transfection experiments o f a human 
myelomonocytic cell line (Iwamoto et al., 1990). Collectively, interactions 
between the virus and mononuclear cells have been viewed as critica l to CMV 
biology, particularly in  dissemination and latency.
Immune Response to CMV Infection
The interaction between CMV and the host’s immune system is complex 
(reviewed in G riffiths and Grundy, 1987; Koszinowski et al., 1990; Mocarski et 
al., 1990). Even in  the immunocompetent host, the virus can itse lf cause 
suppression of host responses, and can infect cells o f the immune system 
(McChesney and Oldstone, 1987; Rinaldo, 1990). Furthermore, eventhough the 
host has evolved antivira l immune defenses to control CMV replication, the 
virus has evolved mechanisms o f evading these host defenses (reviewed in H ill 
and Pleogh, 1994).
The most im portant non-specific host defense against MCMV infection is 
the protective role o f natural k ille r (NK) cells (Bancroft et al., 1981). NK cells 
are quickly activated following MCMV infection and provide the firs t line of
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defense. NK activity correlates w ith the degree o f resistance, and strains of 
mice lacking NK cell function, such as homozygous beige mice, are more 
susceptible to MCMV infection (Shelham et al., 1981). The adm inistration of 
anti-asialo-GMi antibody, to deplete NK cells, increases virus replication in 
tissues and the severity o f infection (Bukowski et al., 1984). The adoptive 
transfer o f NK cells in to  suckling mice o f susceptible strains induces resistance 
to MCMV infection (Bukowski et al., 1985).
Another non-specific defense against CMV, particularly in  the early 
stages o f infection, is the production o f IFN-a/p (Tarr et al., 1978). The 
adm inistration o f antiserum  against IFN-a/p reduces the resistance o f mice to 
MCMV infection, and significantly increases virus titers in the blood and liver 
(Grundy-Chalmer et al., 1982). MCMV-induced IFN-a/P production is pivotal 
for NK cell activity, and mediates the trafficking of these activated cells to 
splenic marginal zones (Biron et al., 1995). This trafficking pattern is believed 
to enhance cell-mediated immune responses by facilitating the delivery o f NK- 
produced cytokines (such as IFN-y) to antigen presenting cells.
In  general, hum oral immune responses do not play an im portant role 
against primary CMV infection (reviewed in  G riffiths and Grundy, 1987). There 
is some evidence in  mice tha t the passive adm inistration o f antibodies to MCMV 
reduces the severity o f disease and, if  given before infection, prevents disease 
(Farrell and Shellam, 1991; Shanley et al., 1981). In immunoglobulin-deficient 
mice, the course and kinetics o f prim ary MCMV infection are unaffected (Jonjic 
et al., 1994). However, the absence o f antibodies in  these animals results in  
signficantly higher virus titers in the salivary glands, spleen, and lungs
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following radiation-induced reactivation. Thus, antibodies are not needed for 
the resolution of primary MCMV infection, but significantly lim it virus 
dissemination during recurrent infection.
The cell-mediated immune response to CMV plays a central role in  
controlling the infection (Koszinowski et al., 1990). Individuals w ith  deficiencies 
in th is arm o f the immune system are a t high risk o f CMV disease (Ho, 1991; 
Nelson et al., 1990). In HCMV infection, the CTL response correlates w ith 
successful resolution o f infection in  bone-marrow-transplant recipients 
(Quinnan et al., 1982). The immunodominant CTL epitopes o f HCMV are 
directed predominantly against the pp65 and pp l50 matrix-tegument proteins 
(Greenberg, 1995), although there are significant CTL responses to the IE72 and 
gB proteins as well (Boiysiewicz et al., 1988). Adoptive immunotherapy in 
bone-marrow-transplant patients using HCMV-specific syngeneic CTLs 
eliminates HCMV disease (Greenberg, 1995). In 13 patients receiving th is 
treatment, none showed HCMV viremia or any other symptoms o f disease.
In a murine model, the adoptive transfer o f MCMV-specific CTL 
completely protects immunosuppressed mice from a lethal challenge w ith 
MCMV, and is therapeutically effective in  animals w ith established infections 
(Reddehase et al., 1985 and 1987). In  BALB/c mice, IE antigens dominate the 
CTL response to MCMV infection (Reddehase et al., 1987), particularly the IE1 
protein pp89 (Volkmer et al., 1987). Remarkably, a single nonapeptide from 
pp89 is the only epitope of th is protein tha t is recognized by BALB/c CTLs (Del 
Val et al., 1988). A recombinant vaccinia virus expressing th is single T-cell 
epitope protects mice against lethal MCMV challenge (Del Val et al., 1991).
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In  infected mice, th is aggressive CTL response begins at seven to ten 
days following infection, and is responsible for clearing virus from all tissues of 
the animal, except the salivaiy gland (Lucin et al., 1992). Persistent, high-level 
growth o f MCMV in  the salivaiy glands is the result of the escape o f acinar 
glandular epithelial cells from CTL recognition (Jonjic et al., 1989). Apparently, 
th is is the only cell type tha t requires the function of T helper lymphocytes, in 
addition to CTL, to clear persistent MCMV infection (Lucin et al., 1992). Mice 
depleted o f CD4+ T lymphocytes develop a chronic MCMV infection in  the 
acinar glandular epithelial cells o f the salivaiy glands (Jonjic et al., 1989). 
Surprisingly, mice depleted of CD8+ T lymphocytes elim inate MCMV w ith  
kinetics sim ilar to tha t o f normal mice (Jonjic et al., 1990). In these mice, the 
CD4 subset gains protective functions and fu lly compensates for the CD 8 
deficiency.
Recovery from prim aiy CMV infection requires the function o f T 
lymphocytes. These T cells lim it virus replication not only by direct cytolytic 
activity against infected cells, bu t also by secreting cytokines at the site o f 
infection (Doherty et al., 1992). In  BALB/c mice, neutralization of IFN-y 
abrogated the ability o f the T h l subset o f CD4+ T lymphocytes to clear MCMV 
from the salivary glands (Lucin et al., 1992). Neutralization o f TNF-a also 
abolished virus clearance from the salivaiy glands, as well as clearance from 
other target organs in  CD8-depleted mice (Pavic et al., 1993). In addition, IFN-y 
and TNF-a act synergistically to drastically inh ib it MCMV replication by 
interfering w ith  MCMV morphogenesis during the late phase o f the virus 
replication cycle (Lucin et al., 1994). These two cytokines also play critica l roles
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in  activating macrophages during MCMV infection in  both immunocompetent 
and immunodeficient (SCID) mice (Heise and Virgin, 1995).
CMV is a persistent virus tha t remains associated w ith its host fo r life 
following prim aiy infection. To accomplish persistence, CMV has evolved 
strategies to escape immune detection, and thereby coexist in  the presence o f 
specific host immune defenses. These immune evasion strategies include: a 
virus-induced immunosuppression (McChesney and Oldstone, 1987; Rinaldo, 
1990), and an inh ib ition o f CTL recognition (Campbell et al., 1989 and 1992).
CMV, like the other herpesviruses, causes immune suppression (Rinaldo, 
1990; McChesney and Oldstone, 1987). The virus can infect cells o f the 
immune system, namely lymphocytes (Schrier et al., 1985) and monocytes 
(Brautigam et al., 1979; Collins et al., 1994; Ibanez et al., 1991; Kondo et al., 
1994; Stoddart et al., 1994). Infection o f these cells, whether abortive or 
productive, im pairs their function and leads to generalized immunosuppression 
(Rice et al., 1984; Schrier et al., 1986a and 1986b). For example, infection o f 
peripheral blood mononuclear cells w ith  HCMV results in  depressed 
proliferative responses o f T lymphocytes to antigen and to mitogen 
(phytohemagglutinin), in suppressed NK cell activity, in  depressed antibody- 
dependent cell-mediated cytotoxicity, reduced interferon induction by mitogens, 
and in  suppressed class I-restricted CTL activity' (Schrier et al., 1984, 1986a, 
1986b). The IE1 and IE2 proteins o f HCMV up-regulate the transform ing 
growth factor-p i (TGF-(31) promoter (Michelson et al., 1994). This induction of 
TGF-pi may contribute to HCMV-induced immunosuppression, since th is  
cytokine can have profound negative effects on immune responses.
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Acute infection o f SV40-immunized mice w ith MCMV prevents the 
activation of SV40-specific CTL precursors (Campbell et al., 1989). MCMV 
infection o f mice also significantly suppresses the prim ing of T helper 
lymphocytes (Slater et al., 1991). These inh ib itory effects of MCMV infection on 
T helper and CTL functions are independent, indicating tha t the virus induces a 
defect in  antigen processing or presentation (Slater et al., 1991). In  vitro, MCMV 
infection o f SV40-transformed fibroblasts and macrophages prevents the 
presentation o f SV40 large T antigen to SV40-specific CTLs (Campbell et al.,
1992). SV40-transformed target cells tha t are infected w ith MCMV are not 
recognized by class I-restricted, SV40-specific CTL clones. This inh ib ition  in 
the presentation o f T antigen requires MCMV early gene expression. 
Interestingly, the presentation o f the immunodominant pp89 epitope to specific 
CTLs in intro is also inhibited during the early phase o f MCMV infection (Del Val 
e ta l., 1989).
CTLs recognize short peptides, derived from  vira l proteins synthesized 
inside the infected cell, and presented at the cell surface by MHC class I 
molecules (Townsend et al., 1989). This process of antigen presentation 
requires that the class I heavy chain assemble w ith  the vira l peptide and P2- 
m icroglobulin in  the endoplasmic reticulum /ds-G olgi to form a stable 
trim olecular complex, which is then exported to the surface of the infected cell 
(Townsend et al., 1989 and 1990). CMV, as well as a number of other viruses, 
inh ib its  CTL recognition by down-regulating the expression of MHC class I 
molecules in infected cells (Barnes and Grundy, 1992; Beersma et al., 1993; 
Campbell et al., 1992; Del Val et al., 1992; Warren et al., 1994; Yamashita et
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al., 1993), suggesting that th is is a common mechanism for immune evasion 
among infectious viruses.
In HCMV infection, marked reduction in  the surface expression o f class I 
molecules is not the result o f a reduction in  the synthesis of either the heavy or 
ligh t chain (Yamashita et al., 1993). Eventhough pulse-chase experiments 
show a drastic reduction in the steady state levels o f human class I heavy 
chains, th is effect is not due to a reduced rate o f synthesis, bu t rather to the 
accelerated degradation of these proteins (Beersma et al., 1993). These effects 
o f HCMV are insensitive to the effects of phosphonoacetic acid, indicating the 
involvement o f IE or E vira l gene products. In  vitro, HCMV infection impairs 
class I assembly (Warren et al., 1994). Further pulse-chase analyses show that 
class I complexes are assembled in  infected cells, but are unstable and are 
rapidly degraded. Im portantly, the decreased surface expression o f class I 
molecules in  HCMV-infected cells is accompanied by resistance to CTL lysis 
(Warren et al., 1994). IFN-y and TNF-a counteract the HCMV-induced 
reduction in  class I expression by greatly increasing class I synthesis and 
assembly (Hengel et al., 1995). Although these cytokines can compensate for 
the negative effect on antigen presentation, HCMV-induced interference w ith 
class I formation remains active. Therefore, th is cytokine effect does not act 
through antivira l activities, bu t instead is associated w ith the induction o f class 
I genes of the host.
In  MCMV-infected cells, early viral gene expression drastically reduces 
the levels of H-2K and H-2D molecules on the surface o f infected fibroblasts 
(Campbell et al., 1992). Treatment w ith IFN-y partially restores class I
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expression, but does not overcome the block in antigen presentation. Pulse- 
chase experiments show tha t MCMV early gene expression drastically reduces 
the synthesis o f class I molecules in  infected cells (Campbell and Slater, 1994). 
MCMV infection prevents m aturation of class I heavy chains to the ir fu lly 
glycosylated forms, and inh ib its their transport from the ER/cis-Golgi to the cell 
surface (Campbell and Slater, 1994; Del Val et al., 1992). Completely 
assembled trim olecular class I complexes form, but are retained before entering 
the medial-Golgi compartment (Del Val et al., 1992). MCMV infection not only 
inhib its the synthesis and transport o f class I heavy chains, but it  also reduces 
the steady-state levels o f class I mRNA (Campbell et al., 1995), indicating that 
the inhib ition in  class I expression may be due, in part, to the reduced 
transcription o f these genes. By inh ib iting the expression of MHC class I 
molecules, CMV lim its  the number o f recognition molecules on the surface of 
infected cells, and thus enables them to escape CTL recognition and persist in 
the host.
Nonessential V ira l Genes 
CMV biology is complex, and understanding the interactions between the 
virus and its  host are necessaiy to unravel the mechanisms of viral 
pathogenesis. The fact tha t CMV infections are persistent and remain largely 
asymptomatic in  the normal host are tributes to the ways in which the virus 
has evolved to live in  equilibrium  w ith its  host. The v ira l genome is estimated to 
encode over 200 genes (Chee et al., 1990; Rawlinson et al., 1993), which serves 
to reinforce its  complicated biology. W ith such a large number of vira l genes,
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any one o f them may be expected to play a subtle role in  the biology o f CMV 
infection.
W ith numerous viruses, the generation and analysis o f m utants have 
proven to be invaluable in  determining the function o f specific vira l genes. The 
construction o f n u ll m utants is useful in  distinguishing those genes im portant 
for v ira l growth from those more im portant in  pathogenesis. Using n u ll 
mutants, vira l genes can be operationally divided into two categories:
1) essential genes, or those required for virus replication in  tissue culture; and
2) nonessential genes, o r those tha t are not required for virus replication in 
tissue culture (Mocarski et al., 1990). Any nonessential gene, encoding a 
protein which does not influence virus growth in  cell culture, m ight instead be 
expected to influence virus/host interactions in vivo. Because the selective 
pressures which exist during propagation in a living host are absent during 
propagation in  cultured cells, it  would make sense tha t genes which encode 
pathogenic factors are nonessential. Nonessential vira l genes probably 
influence various aspects o f pathogenesis in vivo, such as virulence, 
persistence, latency, immune evasion, tissue tropism, virus dissemination, and 
transmission. Furthermore, these nonessential genes are maintained in  natural 
isolates o f viruses (Gooding, 1992), implying that they m ust be of substantial 
value to the virus in  vivo. I t  seems unlikely tha t viruses would conserve any 
unnecessary genes if  they did not serve some useful purpose in  an intact 
animal host.
There are numerous examples o f nonessential vira l genes that play a 
critica l role in pathogenesis in vivo, eventhough they are dispensable for virus
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replication in  vitro (listed in  Table 1). For example, the E3 region o f adenovirus 
2, which encodes a 19-kd protein tha t prevents MHC class I transport to the 
cell surface (Burgert et al., 1985 and 1987) and three additional proteins that 
inh ib it lysis o f infected cells by TNF (Gooding et al., 1988 and 1991), are 
nonessential. In  a rodent model o f adenovirus pneumonia, the deletion of the 
E3 region from the vira l genome results in  a virus w ith  markedly increased 
pathogenicity in vivo (Ginsberg et al., 1989). In  contrast, the deletion of 
nonessential poxvirus genes encoding inh ib ito rs for TNF (Smith et al., 1991) or 
complement fixation (Kotwal et al., 1990), result in  recombinant viruses w ith 
severely reduced pathogenicity in  infected rabbits (Isaacs et al., 1992; Upton et 
al., 1991). Several HSV-1 mutants m issing nonessential genes located in the Us 
and inverted repeat sequences o f the vira l genome are avirulent in  mice (Chou 
et al., 1990; Meignier et al., 1988). A nonessential HSV-1 IE protein, designated 
ICP47, blocks the transport of MHC class I molecules to the cell surface (York et 
al., 1994), possibly by inh ib iting the function o f the transporter associated w ith 
antigen processing (Johnson et al., 1995). In  infected mice, an HSV-1 m utant 
missing the ICP47 gene displays greatly attenuated growth and pathogenicity 
(Johnson et al., 1995).
In HCMV, a cluster of contiguous genes, the IRS1 and US1 through 
US 13 genes, o f the AD 169 strain are nonessential for virus replication in  cell 
culture (Jones et al., 1991 and 1992). Two loci w ith in  th is nonessential region, 
namely US11 and a gene w ith in US2-5, are responsible for the reduction in  
MHC class I expression observed in  HCMV-infected cells (Jones et al.,1995), 
and are presumed to function in  immune evasion and virus persistence.
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However, because there is no experimental animal model for HCMV studies, the 
role o f these nonessential genes in pathogenesis in vivo is not clear.
MCMV M utants
To date, numerous MCMV m utants have been generated (Boname and 
Chantler, 1992; Cardin et al., 1993; Kumura et al., 1990; Manning et al., 1988 
and 1992; Sammons and Sweet, 1989; Sandford and Bums, 1988; Tonari and 
Minamishima, 1983; Vieira et al., 1994). Some o f these represent temperature- 
sensitive (ts) m utants (Sammons and Sweet, 1989; Sandford and Bums, 1988; 
Tonari and Minamishima, 1983), which were generated in a random fashion by 
exposing wild-type (WT) MCMV to ultra-vio let ligh t or to chemical mutagens.
Due to their nature, these viruses are conditionally lethal mutants in which 
alterations lie in  genes essential for virus replication in  vitro, thus their inability 
to grow in cultured cells at nonpermissive temperatures. A few o f these ts 
m utants exhibit reduced in irivo growth and virulence, however, the defects 
responsible for th is phenotyoe have not been fu lly characterized (Kumura et al., 
1990). Because unselected mutations other than temperature sensitivity can 
also exist in  these virus mutants, the task o f characterization is even more 
d ifficu lt.
An alternative method to random-site mutagenesis, used to generate ts 
mutants, is site-directed mutagenesis using a selectable marker gene. This 
method offers the advantages that mutations can be targeted to selected regions 
of the vira l genome, and tha t they lie in  nonessential genes, or those genes 
believed to influence the interactions between the virus and the host. Using 
site-directed insertion and deletion mutagenesis, several MCMV genes have
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been identified as being nonessential. In  1988, Manning and Mocarski 
successfully generated recombinant MCMV by using the E. coli LacZ gene as a 
marker for site-directed insertion into the IE2 gene. This recombinant was the 
firs t defined genetic m utation in  a specific MCMV gene, and demonstrated tha t 
the IE2 gene is nonessential fo r growth in  cultured murine fibroblasts. 
Subsequent in vivo experiments designed to evaluate the function of IE2 in 
replication, tissue tropism, and latency have failed to identify a role for this 
gene in  these aspects o f vira l pathogenesis (Cardin et al., 1993). Since 1988, 
th is group of investigators has constructed several other recombinant viruses 
canying insertions disrupting each of the seven open reading frames encoded 
w ith in  the Hind III-J  region o f the MCMV genome (Vieira et al., 1994). A ll o f the 
genes encoded w ith in  the Hind III-J  fragment are expressed at early times 
during the viral replication cycle, except one, which is expressed at late times.
To date, there are published reports of in vivo studies on only those mutants 
disrupting two o f these seven genes, the gene expressed at late times and a gene 
denoted sggl (for salivary gland growth genel). Like the IE2 gene, a function 
for the late gene has not yet been identified in  the infected mouse (Cardin et al.,
1993). MCMV m utants disrupted in  this late gene show only a slight reduction 
in  salivary gland titers. However, th is phenotype is observed w ith a ll other 
LacZ-tagged viruses, and appears to be independent of the insertion site 
(Lagenaur et al., 1994; Mocarski et al., 1990).
The sggl m utants display drastically reduced growth in the salivary 
glands, while growth in  other organs is not significantly affected (Manning et 
al., 1992). This same phenotype is observed w ith another spontaneous MCMV
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m utant, called the Vancouver strain, which was isolated during the in vitro 
passaging o f the parental virus (Boname et al., 1992). This m utant carries a 
large deletion w ith in  the H ind III-E  fragment and an insertion w ith in  the Hind 
III-D  region o f the vira l genome. Therefore, these findings suggest tha t other 
vira l genes, in  addition to the sggl gene, influence MCMV replication in  the 
salivaiy glands o f infected mice. Another gene located in  the Hind III-J  
fragment encodes a receptor for the Fc domain o f murine immunoglobulin G 
molecules, and is denoted f c r l  (for Fc receptor 1) (Thale et al., 1994). W ith the 
exceptions of the sgg l and f c r l  genes, the functions o f the remaining genes 
encoded w ith in  the Hind III-J  region o f the MCMV genome are not known.
At the present time, the entire MCMV sequence has been determined 
(Rawlinson et al., 1993), although it  has not been published. In spite of this, 
the locations and functions o f only a relatively few number o f the estimated 200 
genes o f th is virus have been characterized. Most of these represent essential 
genes, and include those encoding the IE1 and IE3 proteins, the DNA 
polymerase and MDBP, and envelope glycoproteins B and H. The nonessential 
genes identified to date include the IE2, sgg l, and f c r l  genes. The functions of 
these nonessential genes during infection is not completely understood.
Clearly, additional m utants are needed in  order to identify those MCMV 
sequeces involved in  pathogenesis in vivo.
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n . SPECIFIC OBJECTIVES
The purpose o f th is study was to identify MCMV genes involved in 
pathogenesis in xavo. Our approach to identifying these genes involved 
constructing MCMV m utants, and then analyzing these m utants in vitro and in 
vivo. Recombinant viruses (RV) were constructed by inserting the E. coli (3- 
glucuronidase (P-glu) marker gene into selected regions o f the vira l genome by 
homologous recombination. RV generated by th is method w ill be mutated in 
nonessential genes, those predicted to im pact on the interaction o f MCMV with 
the host animal. Therefore, th is study provides the ideal opportunity in  which 
to examine the effects o f MCMV genes tha t are dispensable for growth in vitro on 
the pathogenesis o f the virus in vivo. Characterizing these genes w ill provide 
im portant inform ation about the molecular mechanisms o f MCMV 
pathogenesis.
The specific objectives o f th is project were to:
1) Construct recombinant MCMV using the B-glu gene as a marker gene. Our 
basic strategy involved inserting the P-glu gene into selected MCMV genomic 
clones. The resulting clones were linearized and cotransfected w ith infectious 
MCMV DNA into NIH3T3 fibroblasts. Following homologous recombination of 
the flanking sequences, plaques containing RV were selected by a blue 
phenotype after overlaying the transfected cells w ith agarose containing the 
chromogenic substrate for the p-glu enzyme.
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2) Analyze recombinant MCMV in vitro to identify viral sequences involved in 
virus growth and MHC class I expression. MCMV recombinants were tested for 
the ir effects on:
a) Growth in  cell lines o f fibroblast and myeloid origin.
b) IE, E, and L gene expression in  these cell lines.
c) MHC class I expression in  a fibroblast cell line.
3) Analyze recombinant MCMV in  a murine model to identify viral genes 
involved in  pathogenesis in  vivo. MCMV m utants were examined for the ir 
effects on growth in  the salivaiy glands, spleen, liver, and lungs o f infected 
mice.
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m . MATERIALS AND METHODS
Cells
NIH3T3 cells, a contact-inhibited murine fibroblast cell line (from 
American Type Culture Collection [ATCC], CRL1658, Rockville, MD), were 
propagated in  Dulbecco’s modified essential media (DMEM, Mediatech,
Herndon, VA) supplemented w ith 10% heat-inactivated bovine ca lf serum 
(Hyclone Laboratories, Logan, UT) and 1% L-glutamine (Gibco/BRL, Grand 
Island, NY). WT-19 cells, derived from C57BL/6 mouse prim aiy kidney 
fibroblasts after transformation w ith  SV40 large T antigen (Tevethia et al.,
1980), were grown in  DMEM containing 10% heat-inactivated fetal ca lf serum 
(Gibco/BRL) and 1% L-glutamine. These cells were kind ly provided by Dr. 
Satvir Tevethia, Pennsylvania State University School o f Medicine (Hershey, PA). 
IC -21 cells, an SV40-transformed peritoneal macrophage cell line from 
C57BL/6 mice (Mauel and Defendi, 1971), were obtained from ATCC and were 
propagated in  RPMI media (Mediatech) supplemented w ith  10% heat-inactivated 
fetal ca lf serum and 1% L-glutamine. Primaiy fibroblasts, derived from  the 
embryos of timed-pregnant BALB/c.ByJ mice (Jackson Laboratories, Bar 
Harbor, MN) on day 19 o f gestation, were cultured in DMEM containing 20% 
heat-inactivated fetal ca lf serum, 1% L-glutamine, and 50 pg/m l o f gentamicin 
sulfate (Sigma Chemical Co., St. Louis, MO). Primaiy embiyo fibroblasts were 
used before reaching the ir fifth  passage in tissue culture.
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Virus
The parental WT MCMV used in  these studies was of the Smith strain 
(from ATCC). Stocks o f virus, WT as well as m utant, were prepared in  and 
titered on NIH3T3 fibroblasts, as previously described (Campbell et al., 1989).
Mice
Male 20-day-old weanling BALB/c.ByJ mice were purchased from 
Jackson Laboratories, and were housed in  m icroisolator cages w ith  sterile food, 
water, and bedding. Mice were injected intraperitoneally (using a 27-gauge 
needle) w ith tissue-culture-passaged virus (1.5 X 10s PFU in  0.1 m l phosphate- 
buffered saline) a t 21 days of age. Animals were sacrificed, a t indicated times 
post-inoculation, by cervical dislocation, a method accepted by the Panel on 
Euthanasia o f the American Veterinary Medical Association.
Restriction endonuclease mapping
The sites for various restriction endonucleases were identified w ith in  the 
MCMV Hind III-F, -J, and -I genomic plasmid clones by standard methods 
(Maniatis et al., 1987). A ll enzymes were purchased from Promega (Madison, 
WI), and digestions were conducted w ith  buffers supplied by the manufacturer, 
according to the provided instructions.
Plasmid constructions
Plasmid cloning was conducted by standard methods (Maniatis et al., 
1987), and restriction endonuclease digestions were done according to 
m anufacturer’s (Promega) suggestions.
A genomic lib rary o f MCMV DNA (Smith strain) was constructed by 
digesting the vira l genomic DNA w ith  Hind III, and then cloning these fragments
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into the Hind III site o f the plasmid vector pGEM-4Z (Promega). The Hind III-F , 
-I, -J, and -L genomic clones were utilized in  th is  study.
The plasmid designated pelp-g lu (shown in  Fig.4A) was constructed in  
the pGEM-7Z vector (Promega), and contains the p-glu reporter gene under the 
control o f the MCMV early region 1 (el) promoter. This e l/p -g lu  cassette 
contains 2.2 kb o f the p-glu gene (derived by digestion o f plasmid pgHBglOpA 
[kindly provided by Dr. Thomas Jones, American Cyanamid Co., Pearl River,
NY] w ith  Nco I and Sst I), coupled to 0.2 kb o f the e l promoter. The e l 
promoter was derived from the 5.5 kb Pst I fragment o f the MCMV Hind III-F  
genomic clone, which contains the entire e l transcription u n it (Buhler et al.,
1990). The promoter consists o f an Sst I to Nco I fragment, containing the firs t 
200 nucleotides upstream o f the sta rt site o f transcription (which is located a t 
the Nco I site). The entire 2.4 kb e l/P -g lu  cassette can be removed from pe ip - 
glu by digestion w ith  Sst I.
A recombination plasmid o f an insertion m utant of the MCMV Hind III-J  
genomic clone, designated p jpglu-5 (shown in  Fig. 4C), was constructed by 
inserting the e l/p -g lu  cassette into the second Sst I site. The Hind III-J  
plasmid was partia lly digested w ith  Sst I, and linearized molecules (m igrating at 
10.9 kb [8.1 kb o f MCMV Hind III-J  sequences and 2.8 kb o f pGEM-4Z 
sequences]) were isolated from a 5% aciylam ide gel. These molecules were 
treated w ith  phosphatase, and then ligated to the gel-purified 2.4 kb e l/p -g lu  
fragment derived from pe l/p -g lu  by Sst I digestion. The resulting clones were 
screened for the location of insertion o f the cassette, and only one o f the two 
possible insertions was generated.
40
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Recombination plasmids o f deletion m utants o f the MCMV Hind III-J  and 
-I genomic clones, designated p jpg lu-6, pJiPglu-7, and pJiPglu-9 (shown in  Fig. 
4C), were constructed by deleting selected genomic sequences and replacing 
them w ith  the e l/P -g lu  cassette. To facilitate in  the construction o f these 
deletion mutants, a plasmid (called p3.4jpglu, shown in  Fig. 4B) was made tha t 
contained only the firs t 3.4 kb o f H ind III-J  coupled to the e l/P -g lu  cassette. 
This plasmid was constructed by completely digesting MCMV Hind III-J  w ith  
Sst I, isolating the large 6.3 kb band (consisting o f vector sequences and the 
firs t 3.4 kb of Hind III-J  sequences) from an aciylam ide gel, and inserting the 
e l/p -g lu  cassette into the Sst I site. Plasmid p3.4 jpg lu  was then partially 
digested w ith Sst I, and linearized molecules (m igrating a t 8.7 kb) were gel 
purified and ligated to other various Sst I-digested fragments from Hind III-J  or 
-I (also gel-purified). To construct p jpglu-6, the 1.9 kb Sst I fragment o f Hind 
III-J  was cloned behind the cassette, thereby deleting 2.8 kb of Hind III-J 
genomic sequences. To create pJIpglu-7, the middle 3.0 kb Sst I fragment o f 
Hind III-I was cloned behind the cassette, resulting in  the deletion of 7.7 kb of 
genomic sequences from  the Hind III-J  and -I regions. To construct pJiPglu-9, 
the 3.7 kb Sst I fragment of Hind III-I was cloned behind the cassette, deleting 
10.7 kb from Hind III-J  and -I.
Isolation o f MCMV DNA 
Intact, infectious MCMV DNA was prepared from virions purified from a 
WT virus stock by sorbitol cushion density gradient centrifugation. Five 
m illilite rs  (ml) o f a 20% sorbitol solution (made in  50 mM Tris-HCl [pH 7.5], 1 
mM MgCfe) was added to the bottom o f polypropylene centrifugation tubes (30
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cc volume, Beckman Instruments, Fullerton, CA). Then, 15 ml o f virus stock 
was very slowly layered on top o f th is sorbitol cushion, being careful not to mix 
the interface. The virions were pelleted by centrifugation at 27,000 x g for 45 
m inutes (Beckman Instruments, centrifuge model JA1000). The liquid from 
each tube was then removed by aspiration, and the pellet was resuspended in 
1.0 m l o f lysis buffer (20 mM Tris-HCl [pH 7.5], 100 mM NaCl, 10 mM EDTA, 
0.1% SDS, 1% N-lauroylsarcosine, and 100 pg/m l proteinase K) overnight at 
room temperature w ith  gentle shaking. The virus lysates from 12 tubes were 
pooled, extracted twice w ith phenol (saturated w ith TE buffer [10 mMTris-HCl, 
pH 7.5, 1 mM EDTA]), once w ith  chloroform (25 parts chloroform to 1 part 
isoamyl alcohol), and precipitated in  70% ethanol overnight at -20° C. The DNA 
was pelleted by centrifugation, washed twice w ith 70% ethanol, briefly dried, 
and resuspended overnight in  5 m l of TE buffer at 4°C. The MCMV DNA was 
quantitated on a spectrophotometer (Spectronic 1001 Plus, M ilton Roy Co., 
Rochester, NY) at 260 nm, aliquoted into sterile eppendorf tubes, and stored at 
-80°C.
Construction of recombinant MCMV 
Recombinant MCMV was generated by cotransfecting infectious MCMV 
DNA and linearized plasmid DNA into NIH3T3 cells, where the DNAs undergo 
homologous recombination to create a m utant viral genome. Plasmid DNAs 
were prepared for cotransfection by digestion w ith Hind III, extraction w ith 
phenol and chloroform, ethanol precipitation, and resuspension in  sterile 
distilled water. The DNAs were cotransfected into NIH3T3 cells using a 
modified calcium phosphate precipitation technique described in Current
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Protocols in Molecular Biology (1990 edition, section I, u n it 9.1, supplement 
14). A total o f 7 jag o f DNA (3 jag o f MCMV DNA and 4 |ag o f linearized plasmid 
DNA) was transfected into 5 X 105 cells in  suspension. The DNAs were added to 
500 pi o f sterile distilled water in  a sterile eppendorf tube, 50 pi o f a 2.5 M CaCb 
solution was added, and the solution was gently mixed. This DNA/CaCb 
solution was then added drop-by-drop to 500 pi o f 2X hepes-buffered saline 
38.4 mM hepes, 274 mM NaCl, 10 mM KC1, 1.6 mM Na2HPO«, 0.2% dextrose, 
pH 7.05) in a sterile 15 m l conical tube. The DNA precipitate was allowed to 
form a t room temperature for 20 minutes. Then 9 m l o f a cell suspension 
(containing 5 X 10s cells in  NIH3T3 culture media) was added to the tube 
containing the DNA precipitate. The entire m ixture was placed into a 100-mm 
tissue culture plate and incubated at 37°C. To increase cellular uptake o f DNA, 
the cells were shocked w ith a 20% dimethyl sulfoxide solution in  NIH3T3 
culture media (2 m l for 3 minutes) at five hours post-transfection. After 
washing the cell monolayers three times w ith phosphate-buffered saline (pH 
7.4), culture media was added to the plate. When the firs t signs of cytopathic 
effect were visible, usually between 6 to 8 days post-transfection, the monolayer 
was overlayed w ith  0.5% agarose. Three or four days later, when the viral 
plaques reached a large size, a second agarose overlay containing 150 pg/m l of 
the X-glu substrate (5-bromo-4-chloro-3-indolyl-p-D-glucuronide, Biosynth Inc., 
Zurich, Switzerland) was applied to the cells. The X-glu diffused through the 
firs t agarose overlay to reach any plaques containing RV expressing the P-glu 
gene. These RV-containing plaques became blue in  color w ith in  24 hours o f the 
second overlay.
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Purification o f recombinant MCMV 
To isolate a pure population o f RV, blue plaques on prim aiy transfection 
plates were picked as agar plugs, and underwent a t least five rounds of plaque 
purification. Blue plaques were picked using sterile Pasteur pipettes, the agar 
plug was placed into 1 m l o f culture media (in a sterile 5 m l snap-cap tube), and 
pipetted up and down several times to break apart the plug and facilitate virus 
release from the agar. This 1 m l inoculum was then used to infect a fresh 
culture plate o f subconfluent NIH3T3 cells. After virus adsorption for 1 hour at 
37°C, the inoculum  was removed and the monolayer was overlayed w ith 0.5% 
agarose. Four or five days later, when virus plaques were large in  size and well- 
developed, the second overlay containing X-glu was added. The following day, 
well-isolated blue plaques were picked, and the cycle was repeated. At the 
fourth round o f purification, only one-tenth o f the 1 m l inoculum was used to 
infect a fresh plate o f cells. This was done to ensure tha t a well-isolated blue 
plaque could be picked w ithout significant chances o f contamination w ith virus 
from any neighboring plaques. A t the fifth  round, a fina l blue plaque was 
placed into 5 m l o f media. Four m l o f th is inoculum was used to infect a flask of 
cells for the purpose o f preparing a high-titered stock o f RV. The remaining 1 
m l was used to infect another plate of cells for the purpose o f isolating infected 
cell DNA for Southern b lo t analysis.
Southern blot analysis 
DNA was prepared from mock-, WT-, or RV-infected NIH3T3 cells as 
previously described (Stenberg et al., 1989), and quantitated a t 260 nm. Mock 
infections utilized cell culture supernatants from noninfected NIH3T3 cells, and 
served as a negative control. Southern blots were conducted as described by
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Maniatis and coworkers (1987). Infected cell DNAs were digested w ith  Hind III 
and Bgl II, or w ith  Bgl II alone, and after digestion, 2 pg o f each sample was 
loaded into the wells o f a 0.8% agarose gel. The DNA fragments were separated 
by electrophoresis overnight a t 22 volts. The following day, the gels were 
stained w ith  ethidium  bromide, and were photographed alongside a fluorescent 
ruler. To facilitate the transfer o f DNA fragments, the gels were soaked in 0.25 
M HC1 for 10 m inutes, followed by incubations in  denaturing solution for one 
hour and neutralizing solution for another hour. DNA fragments were 
transferred to positively-charged nylon membranes (Boehringer Mannheim, 
Indianapolis, IN) overnight in  20X SSC. The following day, the DNA was fixed to 
the membrane by UV cross-linking (150 J) and baking a t 80°C for one hour.
The Boehringer Mannheim Genius System was used to hybridize the 
membranes to probes o f MCMV Hind III-J , -I, or the P-glu gene. This system 
utilizes probes labeled by random prim ing w ith digoxigenin (DIG), and an 
antibody to DIG for chemiluminescent detection. The membranes were exposed 
to XAR5 film  (Fuji) w ith  intensifying screens at room temperature for 15 to 60 
seconds.
The MCMV H ind III-J  and -I probes were made from  gel-purified 
fragments (8.1 kb and 9.7 kb, respectively) following H ind III digestion o f these 
genomic clones. The p-glu probe was made from the gel-purified 2.2 kb Nco I to 
Sst I fragment of plasmid pe l /P-glu.
In  vitro growth o f MCMV m utants
Approximately 1 X 106 cells were seeded into duplicate tissue culture 
flasks (25 cm2) in  5 m l o f culture media. The following day, the cells were
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infected at a m u ltip lic ity  o f infection (moi) o f 0.1 PFU per cell w ith either WT or 
m utant MCMV (for m ulti-step growth curves) in  a one m l inoculum volume. 
After virus adsorption fo r one hour a t 37°C, the inoculum was removed, the cell 
monolayer was washed twice w ith warmed phosphate-buffered saline, and 5 m l 
o f fresh culture media was added to each flask. Flasks were incubated at 37°C 
u n til the indicated day post-infection (the 0 time point was harvested 
immediately). To harvest virus, the flasks were frozen fla t at -100°C, thawed at 
37°C, and the suspension was transferred to a 50 m l conical tube and 
sonicated for 30 seconds. Following centrifugation to remove cellular debris, 
tota l infectious virus in  the supernatants was quantitated by standard plaque 
assay on NIH3T3 cells. For one-step growth curves, the cultures were infected 
at an moi o f 5 PFU per cell.
Northern blot analysis 
Approximately 2 X 106 cells were seeded into 100-mm tissue culture 
plates the day before infection. The cells were mock-infected, or infected w ith 
WT or m utant MCMV a t an moi o f 4 PFU per cell. Following virus adsorption at 
37°C for one hour, the inoculum was removed, the cell monolayer was washed 
w ith warmed phosphate-buffered saline, and 10 m l o f culture media was added. 
For immediate early RNA isolation, to ta l RNA was harvested from cultures at 3 
hours post-infection. For early RNA isolation, phosphonoacetic acid was added 
to the culture media a t a concentration o f 250 pg per m l at the time o f virus 
infection for a duration o f 24 hours. For late RNA isolation, total RNA was 
harvested from  cultures at 24 hours after infection. The Qiagen RNeasy K it for 
total RNA isolation (Qiagen, Chatsworth, CA) was used to harvest RNA from
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infected cells, as described by manufacturer’s instructions. Northern blots were 
conducted as described by Maniatis and coworkers (1987). RNA samples were 
quantitated at 260 nm, and 5 (ig o f each sample was loaded into the wells o f 
1.5% agarose/6.6% formaldehyde gels and electrophoresed overnight a t 22 
volts. The following day, the gels were rinsed three times in  sterile distilled 
water (10 minutes per wash), and transferred to positively-charged nylon 
membranes overnight in  20X SSC. After transfer, the membranes were UV 
cross-linked (150 J), and baked at 80°C for 30 minutes. The Boehringer 
Mannheim Genius System was used to hybridize the membranes to probes of 
Hind III-L (containing the IE1 and IE2 genes), e l, or gB.
The Hind III-L  probe was made from the gel-purified 7.3 kb fragment 
following Hind III digestion of th is MCMV genomic clone. The e l probe was 
made from the gel-purified 1.4 kb Nco I to Eco RI fragment derived from the 5.5 
kb Pst I fragment o f MCMV Hind III-F. The gB probe was made from the gel- 
purified 3.5 kb Bam HI to Pvu II fragment derived from plasmid pLig3.5 (kindly 
provided by Dr. U lrich Koszinowski, University o f Heidelberg, Heidelberg, 
Germany).
The 2.75 kb IE 1 RNA transcript, the 2.60 kb e l transcript, and the 3.30 
kb gB transcript were quantitatively estimated by densitometric scanning o f 
autoradiographs. The Sun UNIX-SPARC station 5 densitometer (Mountain 
View, CA), equipped w ith  an OmniMedia 12cx-XRS scanner (Torrance, CA), was 
used to scan and analyze autoradiographs. The Bio-Image (Ann Arbor, MI) 
whole band analyzer program was used to quantitate the integrated intensities 
o f these transcripts from  scanned autoradiographs. The integrated intensity is
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expressed as the volume of a band, calculated by summing the volume o f each 
pixel w ith in the boundaries o f the band (area x height) and then subtracting the 
background for each pixel.
Western b lo t analysis 
Western immunoblots were conducted as previously described (Pari and 
St. Jeor, 1990). WT-19 fibroblasts were seeded at 1 X 106 cells per 100-mm 
culture plate w ith  media containing 50 U /m l o f recombinant mouse interferon-y 
(Gibco/BRL). The following day, cells were mock-infected w ith  NIH3T3 
supernatant or infected w ith virus (WT or mutant) at an moi o f 2 PFU per cell. 
Cell lysates were prepared at 24 hours after infection, and were precleared w ith 
purified mouse IgG (Cappel Organon Teknika Corp., Durham, N.C.) and protein 
A-sepharose beads (Sigma Chemical Co.) overnight at 4°C w ith  rotation. 
Following centrifugation, equal volumes o f precleared lysates were boiled for 5 
m inutes, subjected to SDS-PAGE on 12.5% gels, and transferred to 
nitrocellulose membranes (Boehringer Mannheim). The blots were treated w ith 
protein-blocking solution overnight a t 4°C, and then incubated w ith a prim aiy 
antibody for one hour a t room temperature. A conformational-independent 
antibody to murine H-2Kb (anti-peptide 8) or rabbit IgG (control) served as 
prim aiy antibodies. The blots were washed three times, and incubated w ith a 
horseradish peroxidase (HRP)-conjugated mouse anti-rabbit secondaiy antibody 
(Fischer Biologicals) fo r one hour a t room temperature. Following three more 
washes, antibody binding was detected by chemiluminescence (Amersham Life 
Science ECL Kit) on Fuji XAR5 film .
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In  vivo growth o f MCMV m utants
Three-week-old BALB/c.ByJ weanling mice (Jackson Laboratories, Bar 
Harbor, MN) were inoculated w ith 1.5 X 105 PFU o f tissue-culture-passaged 
virus (WT or mutant) by intraperitoneal injection. A t the indicated time post­
inoculation, mice were sacrificed by cervical dislocation, and their submaxillary 
salivaiy glands, spleens, livers, and lungs were removed. The organs were 
weighed, and a 20% (weight/volume) tissue homogenate was prepared in  
Iscove’s complete media (Iscove’s base [Mediatech], 10% heat-inactivated fetal 
bovine serum, 1% L-glutamine, and 50 pg/m l gentamicin sulfate) using ground 
glass tissue homogenizers. Homogenates were transferred to 15 m l conical 
tubes, sonicated for 30 seconds, and centrifuged for 5 minutes. The resulting 
supernatants were titered on NIH3T3 cells by standard plaque assay.
For determinations o f virus growth in  footpads, eight-week-old 
BALB/c.ByJ male mice were anesthetized w ith  an intraperitoneal injection of 
1.3 mg o f sodium pentabarbital (equivalent to 0.01 m g/kg of body weight) prior 
to footpad inoculations. The mice were then injected subcutaneously (using a 
30-gauge needle) w ith  1.5 X 105 PFU o f WT or m utant virus (in 0.1 m l o f 
phosphate-buffered saline) in  each hind footpad. A t 4 days post-inoculation, 
the mice were sacrificed and their hind footpad tissue was removed w ith  a 
scalpel. The hind footpads from 2 animals were pooled, weighed, and a 10% 
(weight/volume) homogenate was prepared in  Iscove’s complete media using 
ground glass tissue homogenizers. The homogenate was then transferred to a 
15 m l conical tube, sonicated for 30 seconds, centrifuged for 5 m inutes, and the 
resulting supernatant was titered on NIH3T3 cells by standard plaque assay.
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IV. RESULTS
Preparations necessary for constructing recombinant MCMV
Recombinant viruses (RV) expessing the E. coli 3-glucuronidase (3-glu) 
m arker gene were constructed by site-directed insertion and deletion 
mutagenesis o f the MCMV genome. Our basic strategy involved inserting the 3- 
glu gene into selected MCMV genomic plasmid clones. The resulting plasmids, 
containing the 3-glu marker gene and interupted or missing genomic 
sequences, were linearized and cotransfected w ith  infectious MCMV DNA into 
m urine NIH3T3 fibroblasts. Following homologous recombination between the 
linearized plasmid DNA and the MCMV DNA, plaques containing m utant 
viruses were selected by a blue phenotype after overlaying the transfected cells 
w ith  agarose containing the chromogenic substrate for the 3-glu enzyme (called 
X-glu).
Prerequisite experiments were conducted to obtain necessary information 
and to establish the optimal conditions needed to generate MCMV m utants by 
th is  method. These in itia l experiments included the following: (1) mapping 
restriction endonuclease sites w ith in  selected MCMV genomic clones,
(2) coupling the 3-glu gene to a suitable promoter that functions during MCMV 
infection, (3) constructing recombination plasmids of mutated MCMV genomic 
clones containing the 3-glu marker gene, (4) isolating intact MCMV DNA from
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purified virions, and (5) developing a transfection protocol for linearized plasmid 
DNA and MCMV DNA tha t results in  productive infection.
Mapping restriction endonuclease sites w ith in  MCMV Hind III-J  and -I 
Two genomic clones, fragments J and I, were selected from a Hind III 
library o f the Sm ith strain MCMV genome to mutate and analyze in  th is study. 
Mutations were targeted to th is region o f the MCMV genome for two reasons. 
F irst, the Hind III-J  and -I fragments of MCMV correspond, in  map units, to a 
cluster o f dispensable HCMV genes, specifically the IRS1 and US1 through 
US 13 genes (see Fig. 2). The MCMV and HCMV genomes share conserved 
blocks o f homologous gene families, which show sim ilar map positions and 
organizations (Messerle et al., 1992; Mocarski et al., 1990; Rawlinson et al.,
1993). Therefore, it  was likely tha t regions in  the Hind III-J  and -I fragments of 
MCMV would be nonessential. Secondly, two loci w ith in  the nonessential 
HCMV region shown in  Figure 2, namely a gene w ithin US2-5 and the US 11 
gene, are involved in  down-regulating MHC class I expression in  infected human 
cells (Jones et al., 1995). Therefore, it seemed reasonable to assume that the 
corresponding region o f the MCMV genome, included w ith in  Hind III-J  and -I, 
may also encode a related nonessential MCMV gene w ith a sim ilar function. To 
facilitate in  the construction and characterization of MCMV m utants in  this 
region o f the vira l genome, the sites for various restriction endonucleases were 
determined w ith in  the MCMV Hind III-J and -I fragments (shown in  Fig. 3).
Coupling the B-glu gene to the e l promoter 
Jones and coworkers demonstrated tha t the p-glu gene is an efficient and 
stable marker for detecting recombinant HCMV (Jones et al., 1991 and 1992).
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To generate recombinant MCMV using this detection system, the 3-glu gene 
m ust firs t be placed under the control o f a promoter tha t w ill function during 
MCMV infection. We chose the MCMV early region 1 (el) promoter to drive the 
expression o f the P-glu gene. This promoter is efficiently activated by the IE1 
and IE3 proteins o f MCMV, and is located w ith in  the Hind III-F  fragment o f the 
vira l genome (Buhler et al., 1990). Therefore, plasmid p e l/p -g lu  (shown in  Fig. 
4A) was constructed to contain a cassette of the P-glu reporter gene coupled to 
the e l promoter (representing the firs t 200 nucleotides upstream of the start 
site o f transcription).
This e l/p -g lu  cassette was found to efficiently express the P-glu enzyme 
in  response to MCMV infection in transient transfection experiments. Plasmid 
pe l/P -g lu  was transfected into NIH3T3 cells (20 pg of DNA/1 X 106 cells) by 
calcium phosphate precipitation. The following day, the transfected cells were 
infected w ith MCMV (moi o f 2), the virus inoculum  was removed, and the cells 
were overlayed w ith  agarose containing X-glu (75 pg/m l). W ithin 48 hours after 
infection, approximately 40 to 50 blue foci were visible on each plate o f 1 X 106 
cells.
Construction o f recombination plasmids o f mutated MCMV genomic clones 
containing the B-glu marker gene 
In th is study, the generation o f recombinant MCMV involved inserting 
the e l/p -g lu  cassette into the Hind III-J  and -I regions o f the vira l genome by 
homologous recombination. In  order for efficient homologous recombination to 
occur, plasmids o f the mutated genomic clones m ust be designed so tha t the
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e l/P -g lu  cassette is flanked on either side by approximately 1.5 kb o f MCMV 
genomic sequences (Jones, personal communication).
A recombination plasmid o f an insertion m utant of the MCMV Hind III-J 
genomic clone, designated p jpg lu-5 (shown in  Fig. 4C), was constructed by 
inserting the e l/p -g lu  cassette (removed from plasmid pe l/p -g lu  by digestion 
w ith  Sst I) into the second Sst I site w ith in  Hind III-J . Recombination plasmids 
representing deletion mutants o f the H ind III-J  and -I genomic clones, 
designated p jpg lu-6 , pJIpglu-7, and pJipglu-9 (shown in  Fig. 4C), were 
constructed by deleting selected genomic sequences from  Hind III-J  and -I and 
replacing them w ith  the e l/p -g lu  cassette. To facilitate in  the construction of 
these deletion recombination plasmids, an additional plasmid was made tha t 
contained only the firs t 3.4 kb o f H ind III-J  cloned in  front of the e l/p -g lu  
cassette. Partial digestion of th is  plasmid, called p3.4Jpglu (shown in  Fig. 4B), 
w ith  Sst I produced a linearized molecule opened a t the 3’ end o f the P-glu gene. 
Then, various Sst I fragments derived from Hind III-J  or -I were cloned behind 
the P-glu gene, in  the correct orientation, to create deletions in  MCMV genomic 
sequences. To construct p jpglu-6, the 1.9 kb Sst I fragment o f Hind III-J  was 
cloned behind the cassette, thereby deleting 2.8 kb o f Hind III-J  genomic 
sequences. To create pJiPglu-7, the middle 3.0 kb Sst I fragment o f Hind III-I 
was cloned behind the cassette, resulting in  the deletion of 7.7 kb o f genomic 
sequences from the Hind III-J and -I regions. To construct pJipglu-9, the 3.7 
kb Sst I fragment o f Hind III-I was cloned behind the cassette, deleting 10.7 kb 
from Hind III-J  and -I. Cotransfections o f these recombination plasmids w ith  
in tact MCMV DNA was predicted to in terupt or delete sequences o f MCMV Hind
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III-J  and -I, provided tha t the recombination events between the plasmid and 
vira l DNAs were homologous.
Isolation of infectious MCMV DNA and development o f a transfection protocol
for recombinant MCMV 
The MCMV genome represents a linear, double-stranded DNA molecule 
that is approximately 230 kb in  length (Rawlinson et al., 1993). This v ira l DNA 
molecule, by itself, is infectious when introduced into permissive cells by 
transfection. O ur methods for generating m utant MCMV rely on cotransfecting 
infectious MCMV DNA and linearized recombination plasmids into NIH3T3 
fibroblasts, where the DNAs can then undergo homologous recombination to 
create a m utant v ira l genome. Therefore, it  was necessaiy to isolate in tact 
MCMV DNA from  virions, and to develop a protocol for transfecting th is vira l 
DNA into cells tha t resulted in  productive infection.
MCMV virions were purified from a virus stock by sorbitol cushion 
density gradient centrifugation. The pelleted virions were then lysed, and the 
viral DNA was carefully isolated as described in  the Materials and Methods 
section. This purified MCMV DNA was transfected into NIH3T3 fibroblasts 
using a modified calcium phosphate precipitation technique (Current Protocols 
in  Molecular Biology, 1987). Determinations for the optim al amount o f DNA to 
transfect and the cell number were experimentally derived by titra tion. The best 
results were achieved when a total of 7 jig o f DNA (including MCMV DNA and 
ca lf thymus DNA, as a carrier) was transfected into 3 X 106 cells in  suspension. 
To increase the cellular uptake o f DNA, cells were shocked w ith  20% dimethyl
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sulfoxide a t five hours post-transfection. Figure 5 shows the number o f viral 
plaques resulting from various amounts o f transfected MCMV DNA.
This basic transfection protocol for productive infection was then applied 
to transfection for recombinant MCMV. For these experiments, 3 pig o f MCMV 
DNA (enough to produce approximately 140 plaques per 100-mm tissue culture 
plate) was cotransfected w ith  4 jig o f H ind Ill-linearized plasmid DNA (one of 
those shown in  Fig. 4C). When the firs t signs o f cytopathic effect were visible, 
a t approximately 6 to 8 days post-transfection, the cells were overlayed w ith 
0.5% agarose. A few days later, when the plaques were large and well- 
developed, a second agarose overlay containing X-glu was applied to the cells. 
The X-glu substrate diffused through the firs t agarose overlay to reach any 
plaques containing recombinant virus expressing the P-glu enzyme. These 
recombinant virus-containing plaques became blue in color w ithin 24 hours of 
the second overlay. Typically, there were 4 to 6 blue plaques visible per 100- 
mm plate, indicating tha t about 3% to 4% of the total plaques on the plate 
contained recombinant virus.
Generation o f recombinant MCMV
Using the methods described above, four MCMV m utants were 
generated: RV5, RV6, RV7, and RV9 (shown in  Fig. 6). RV5 was generated 
using the recombination plasmid pJpglu-5 in cotransfections w ith  MCMV DNA, 
and is an insertion m utant in  which the e l/P -g lu  cassette was inserted a t the 
second Sst I site w ith in  Hind III-J. RV6 was constructed using the 
recombination plasmid pJ3glu-6 in cotransfections, and represents a deletion 
m utant in  which 2.8 kb o f vira l sequences w ith in  Hind III-J  were deleted and
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replaced w ith the el/(3-glu cassette. RV7 was generated w ith the recombination 
plasmid pJipglu-7, and is a deletion m utant missing 7.7 kb o f MCMV 
sequences, 4.7 kb from Hind III-J  and 3.0 kb from Hind III-I. And RV9 is a 
deletion m utant, constructed using the recombination plasmid pJipglu-9, that 
lacks 10.7 kb of MCMV sequences, 4.7 kb from Hind III-J and 6.0 kb from  Hind 
III-I.
Each RV was subjected to at least five rounds o f plaque purification, 
before a high-titered virus stock was prepared. Southern b lo t analyses were 
then conducted w ith DNA isolated from RV-infected NIH3T3 cells, to verify each 
targeted mutation to the MCMV genome, and to determine if  any contaminating 
WT virus was present in  the RV stocks. Figure 7 illustrates the results o f these 
Southern blot analyses using probes to H ind III-J , H ind III-I, and the p-glu 
gene. Table 2 lists the sizes o f the expected hybridizing DNA fragments 
resulting from digestion w ith  the indicated restriction endonucleases (RE) and 
hybridization w ith the indicated probe (Fig. 4C includes RE sites used for these 
size determinations). For a ll four m utants, the sizes o f the recombinant bands 
were exactly what was predicted from the RE map o f the Hind III-J  and -I 
regions (see Figs. 3 and 4C), verifying tha t the recombination events between 
the plasmid and MCMV DNAs were homologous. In  addition, over-exposures of 
the Southern blots o f RV5, RV6, and RV7 failed to reveal the presence o f WT 
bands, indicating that the stocks o f these m utant viruses were pure and free of 
any WT MCMV. In contrast, Southern b lo t analysis o f RV9 clearly revealed the 
presence o f WT bands in  addition to the recombinant bands. I t  was evident 
from these blots that approximately one-half o f the vira l DNA isolated from cells
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infected w ith RV9 is WT MCMV DNA. Three independent attempts were made 
to further purify the RV9 stock, but were unsuccessful. This finding suggested 
tha t RV9 is a helper-dependent m utant, in  tha t its  replication required the 
presence o f WT MCMV. The deletions constructed in th is virus must, therefore, 
extend into an essential region o f the viral genome, and WT virus acts as a 
“helper” to provide an essential gene product in  trans. Because the isolation of 
a pure RV9 stock was not possible, th is m utant was not included in  subsequent 
experiments described below.
In  vitro growth o f MCMV m utants in  cells o f fibroblast and myeloid origin
To assess whether MCMV Hind III-J  or -I sequences have a role in  the 
growth o f virus in  cell culture, the growth rate o f WT and m utant viruses were 
determined in  m urine fibroblast and macrophage cell lines. In  vitro, CMV is 
routinely propagated in fibroblasts, and has been extensively adapted to growth 
in th is cell type. V irus growth was examined in  immortalized fibroblasts 
(NIH3T3 cells), as well as in  prim aiy fibroblasts isolated from BALB/c mouse 
embryos. V irus growth in tissue-culture-adapted macrophages was also 
examined, because th is cell type plays an im portant role during pathogenesis, 
particularly in  dissemination and latency. Although, in vivo, the virus 
characteristically replicates in  epithelial cells, there are no available epithelial 
cell lines in which to test the in  vitro growth rate o f these m utants.
Figure 8 represents m ulti-step growth curves of the MCMV m utants in  
NIH3T3 fibroblasts (shown in  Fig. 8A), and in  prim aiy embiyo fibroblasts 
(shown in Fig. 8B). In th is experiment, subconfluent cultures of cells were 
infected w ith virus at a m u ltip lic ity  of 0.1 plaque-forming un its (PFU) per cell, or
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one in  eveiy ten cells was infected. Then, a t the indicated times following 
infection, to ta l virus (intracellular and extracellular) was harvested and 
quantitated. In  th is type o f growth curve, the amount o f virus at each time 
point depends on both the rate o f virus replication, as well as virus spread from 
cell to cell. The growth rate o f each RV in  NIH3T3 fibroblasts (see Fig. 8A) was 
sim ilar to tha t o f WT MCMV, confirm ing tha t the m utations introduced into 
these viruses are nonessential for MCMV replication in  cultured fibroblasts. 
Although the growth o f RV7 in itia lly  was lower than tha t o f the other viruses, 
th is difference was less than one log and was evident for only the firs t three 
days post-infection. By the fourth day after infection, the levels o f RV7 were 
almost identical to those of WT MCMV. In prim aiy embiyo fibroblasts (see Fig. 
8B), RV7 grew as efficiently at WT virus, indicating that this large deletion to 
the MCMV genome did not affect virus growth in  prim aiy fibroblasts.
Figure 9 A shows m ulti-step growth curves o f the mutant viruses in IC-21 
macrophages, an SV40-transformed peritoneal macrophage cell line, which is 
fu lly  permissive for WT MCMV infection. In th is fully-differentiated macrophage 
cell line, RV5 and RV6 grew sim ilarly to WT virus, however, the growth o f RV7 
in these cells was significantly reduced, by as much as 1,000-fold.
The reduced growth rate o f RV7 in  IC -21 macrophages could be the 
result o f a defect in  virus replication, a defect in  cell-to-cell spread, or defects in  
both replication and spread. To distinguish among these possibilities, a one- 
step growth curve o f RV7 was conducted in these macrophages (shown in Fig. 
9B). In th is experiment, the cultures were infected w ith 5 PFU per cell to 
ensure tha t a ll o f the cells were infected simultaneously. Therefore, any
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differences observed between viruses reflects differences in  virus replication, 
since any effects o f cell-to-cell spread are eliminated. Again, the growth o f RV7 
was significantly lower than that o f WT MCMV, by 100-fold from day 2 post­
infection. The reduction in  RV7 growth in  th is experiment was approximately 
one log less than tha t observed in  the previous experiment. These data indicate 
that the reduced growth o f th is m utant in  IC-21 macrophages is prim arily due 
to a defect in  virus replication, although a defect in  cell-to-cell spread may play 
some, albeit a m inor, role. In  addition, th is experiment clearly demonstrates 
that the reduced growth o f RV7 in these macrophages is not merely the result of 
a slower replication rate, since WT and RV7 viruses reached their peak levels by 
2 days post-infection and then remained a t these levels for the duration o f the 
experiment.
In  a ll o f the in  vitro growth curves described above, virus titers were 
quantitated by standard plaque assay on NIH3T3 fibroblasts. In  these plaque 
assays, it  was consistently observed tha t RV7 produced plaques tha t were 
smaller in  size than those produced by WT MCMV or the other mutants. This 
observation suggests tha t RV7 may have reduced capabilities in  cell-to-cell 
spread in  NIH3T3 fibroblasts. However, th is defect is probably m inor, as is also 
the case in IC-21 macrophages, and does not impact significantly on the growth 
of RV7 in  these fibroblasts.
In  vitro analysis o f IE. E. and L gene expression in RV7-infected cells
To further investigate the defect in RV7 replication in  IC-21 
macrophages, Northern blot analyses were conducted to determine a t which 
stage o f the replication cycle the block in  growth occured. Total RNA was
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isolated from infected NIH3T3 and IC-21 cells under immediate early, early, or 
late conditions; and was hybridized to probes of known IE, E, or L genes, 
respectively (shown in  Fig. 10). Figure 10A is a Northern blot o f immediate 
early RNAs, isolated at three hours post-infection, hybridized to a probe of the 
IE1 and IE2 genes (both contained w ith in  the Hind III-L  fragment). IE1 gene 
expression (represented by the 2.75 kb transcript) in  RV7-infected IC-21 
macrophages was greatly reduced, when compared to levels observed in WT- or 
RV6-infected cells. Densitometric scanning o f the autoradiograph revealed over 
an 8-fold reduction in  the levels o f the 2.75 kb IE1 transcript in  RV7-infected 
cells as compared to WT MCMV-infected cells (integrated intensities o f 10.25 for 
RV7 and 82.67 for WT MCMV). In  contrast, there were no significant 
differences in IE 1 gene expression among WT and m utant viruses in  infected 
NIH3T3 cells (integrated intensities o f 37.24, 32.56, and 37.96 for WT-, RV6-, 
and RV7-infected cells, respectively). This reduction in  RV7 IE gene expression 
in IC-21 macrophages correlates w ith the reduced growth o f th is m utant virus 
in  these cells, and strongly suggests tha t the block in  RV7 replication occured 
at or before the immediate early phase o f virus replication.
Because subsequent virus gene expression in permissive cells is 
dependent on IE gene products, one consequence of reduced IE gene expression 
would be reduced E and L gene expression as well. Therefore, E and L gene 
expression were also investigated by Northern blot analyses in RV7-infected IC- 
21 macrophages. Total RNA was isolated from infected NIH3T3 and IC -21 cells 
under early conditions (at 24 hours post-infection in the presence o f 
phosphonoacetic acid, an inh ib ito r of the vira l DNA polymerase) and was
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hybridized to a probe o f the e l gene (shown in Fig. 10B), which produces two 
transcripts o f 2.6 and 3.0 kb. The 2.6 kb transcrip t represents the fu lly 
processed e 1 mRNA, and during a normal infection o f prim aiy embiyo 
fibroblasts (in the absence o f phosphonoacetic acid), the larger 3.0 kb RNA 
species is seen m ainly a t 2 hours post-infection and quickly disappears after 
this time point (Buhler et al., 1990). The strong expression o f the 3.0 kb 
species in  th is  experiment may be related to the presence of phosphonoacetic 
acid to selectively restrict MCMV replication to the immediate early and early 
phases o f replication. However, because the 2.6 kb species represents the 
mature mRNA for the e l gene, differences in  the expression o f th is  transcript 
were compared among WT- and mutant-infected cells. Expression of the 2.6 kb 
e l transcript in  RV7-infected IC-21 macrophages was reduced over 6-fold 
compared to expression in  WT-infected cells (integrated intensities of 2.39 for 
RV7 and 14.62 for WT MCMV). Whereas, there were no significant differences 
in e l expression between WT and RV7 viruses in  infected NIH3T3 fibroblasts 
(integrated intensities o f 24.41 for WT MCMV and 20.49 for RV7).
To examine L gene expression, tota l RNA was isolated a t late times (at 24 
hours after infection), and was hybridized to a probe o f the glycoprotein B (gB) 
gene, a true L gene in  MCMV (shown in  Fig. 10C). In  IC-21 macrophages, there 
was over a 20-fold reduction in  the levels of gB transcripts (m igrating at 3.3 kb) 
in  RV7-infected cells as compared to WT-infected cells (integrated intensities of 
0.27 for RV7 and 5.47 for WT MCMV). In  NIH3T3 fibroblasts, the levels of gB 
transcripts in  RV7-infected cells were also reduced, by less than 5-fold, when 
compared to WT-infected cells (integrated intensities o f 2.44 for RV7 and 11.69
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for WT MCMV). The reason for th is reduction in RV7-infected NIH3T3 cells is 
unknown, but may be related to the in itia lly  delayed kinetics o f RV7 replication 
in  these cells (see Fig. 8A), or to the smaller plaque size consistently observed 
w ith RV7 infection in  these cells. Nevertheless, the drastically reduced L gene 
expression evident in  RV7-infected IC-21 macrophages correlates w ith the 
significantly reduced levels o f IE and E gene expression, and suggests tha t poor 
replication o f RV7 in  these cells is due to inadequate IE vira l gene expression.
In vitro analysis o f RV7 entry 
A possible explanation for the defect in  RV7 replication and reduced IE 
gene expression in  IC-21 macrophages is tha t RV7 is not entering these cells as 
efficiently as WT MCMV. Perhaps the defect lies upstream o f IE gene 
expression, during the attachment and penetration phases o f infection. To 
investigate th is possibility, duplicate cultures of cells were infected 
simultaneously, and at three hours post-infection, RNA was harvested from one 
culture for Northern blot analysis (of IE1 gene expression) and DNA was 
harvested from the other culture for Southern blot analysis (of input vira l DNA) 
(shown in  Fig. 11). I f  RV7 does not enter IC-21 macrophages as efficiently as 
WT MCMV enters, then the Southern blot should reveal a band o f lesser 
intensity in  the DNA isolated from RV7-infected cells as compared to WT- 
infected cells. On the contrary, the Southern blot (see Fig. 11A) clearly 
demonstrates tha t RV7 entered these macrophages as efficiently as WT MCMV. 
Densitometric scanning o f the autoradiograph revealed veiy sim ilar intensities 
of the v ira l DNA present in  RV7- and WT-infected cells at three hours post­
infection (integrated intensities of 10.12 for RV7 and 10.80 for WT MCMV). In
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NIH3T3 cells, the entry of RV7 appeared to be slightly less than that o f WT 
MCMV (integrated intensities of 13.06 fo r RV7 and 21.07 for WT MCMV), 
although th is difference is less that 2-fold and is probably not significant.
Results o f the simultaneous Northern blot (see Fig. 1 IB) were s imilar  to 
those shown in  Figure 10A. There was almost a 9-fold reduction in  the levels o f 
the IE1 transcript present in  RV7-infected IC-21 macrophages when compared 
to WT-infected cells (integrated intensities o f 1.99 for RV7 and 17.11 for WT 
MCMV). In NIH3T3 fibroblasts, there was a slight reduction in  the levels of IE1 
transcripts in  RV7-infected cells as compared to WT-infected cells (integrated 
intensities o f 5.33 for RV7 and 9.58 fo r WT MCMV). However, this difference is 
less than 2-fold, and may reflect the slightly reduced entry of RV7 into these 
cells in  this particular experiment (see Fig. 11A). Collectively, these data 
demonstrate tha t the reduction in  IE gene expression observed in IC-21 
macrophages infected w ith  RV7 is not the result o f a defect in virus entry.
In  vitro analysis o f effects of MCMV m utants on MHC class I expression
It is well-established that both MCMV and HCMV down-regulate the 
expression o f MHC class I molecules on the surface o f infected cells (Barnes et 
al., 1992; Beersma et al., 1993; Campbell et al., 1992 and 1994; Del Val et al., 
1992; Jones et al., 1995; Yamashita et al., 1993), although the mechanisms o f 
th is reduction by these viruses are different. Two HCMV loci involved in  class I 
down-regulation, specifically the US2-5 and US 11 loci, have been identified 
w ith in  the cluster of nonessential HCMV genes shown in Figure 2 to align, in 
map units, w ith  the Hind III-J  and -I fragments of the MCMV genome (Jones et 
al., 1995). Because the genomes of HCMV and MCMV show a colinear
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arrangement o f many genes (Messerle et al., 1992; Mocarski et al., 1990; 
Rawlinson et al., 1993), the nonessential regions identified in  Hind III-J  and -I 
o f the MCMV genome may encode a related gene involved in class I down- 
regulation in infected murine cells. Therefore, the MCMV m utants were 
analyzed by Western blot w ith  an antibody to the H-2Kb class I heavy chain to 
determine if  sequences w ith in  Hind III-J  or -I were involved in  MHC class I 
expression (shown in  Fig. 12). WT MCMV, as well as RV5, RV6, and RV7, 
significantly reduced the level o f the H-2Kb heavy chain in  infected fibroblasts. 
This indicated that the nonessential regions of Hind III-J  and -I missing in these 
m utants were not involved in  class I down-regulation. I f  these regions o f the 
MCMV genome were involved in  th is phenomenon, then these m utants would 
have failed to down-regulate class I expression, and class I levels sim ilar to 
those observed in mock-infected cells would have been expected.
In vivo analysis o f MCMV m utants 
To assess the ability o f recombinant MCMV to replicate in itivo, the 
growth o f each m utant virus was determined in  the salivaiy glands, spleen, 
liver, and lungs o f infected mice. BALB/c weanling mice were inoculated w ith 
tissue-culture-passaged virus by the intraperitoneal route, and virus titers in  
these organs were determined a t 3, 7, 10, and 14 days after inoculation. In  the 
salivaiy glands (shown in  Fig. 13A), the replication o f RV5 was significantly less 
than tha t o f WT MCMV, reaching a peak tite r at 14 days post-inoculation tha t 
was two logs lower than peak WT levels. The replication of RV6 in the salivaiy 
glands was even lower than tha t of RV5, reaching peak levels tha t were four 
logs less than that observed for WT virus. And most dramatically, RV7 could
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not be detected by standard plaque assay o f salivary gland homogenates in  this 
experiment.
To determine i f  the growth o f these m utant viruses in  the salivary gland 
was perhaps delayed, titers in  th is  organ were determined at 2, 4, and 6 weeks 
after intraperitoneal inoculation (shown in  Fig. 13B). Again, at 2 weeks post­
inoculation, RV5 grew to the highest tite r among the m utants, but was less 
than tha t o f WT MCMV. However, th is difference was less than one log in  this 
experiment, maybe because the glands from three animals were pooled before 
homogenization (whereas each gland was homogenized and titered individually 
in  the previous experiment). A t th is same time point, RV6 grew poorly (three 
logs lower than tha t o f WT MCMV) and RV7 was barely detectable. By 6 weeks 
post-inoculation, the titers for a ll the viruses were no longer detectable by 
plaque assay, indicating that these m utants do not display a delayed kinetics 
for salivary gland growth. Instead, it  is evident that the genes deleted in these 
viruses are required for the efficient replication o f MCMV in  the salivary gland.
It  is interesting to note that the more extensive the m utation in  the vira l 
genome, the poorer the ability o f the m utant virus to replicate in  the salivary 
gland. This suggests tha t m ultiple genes may be involved in salivary gland 
growth, and that the effects o f deleting increasing numbers o f these genes may 
be additive on reducing salivary gland growth.
In the spleens o f infected mice, WT MCMV could be detected on days 7 
(at an average o f 104 PFU/ml o f homogenate) and 10 (average o f 10 PFU/ml). 
However, none o f the m utant viruses could be detected in  the spleen a t any of 
the four time points examined. In the lungs, WT virus was detected only on day
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10 post-inoculation, a t a tite r o f 1,020 PFU/m l of homogenate. Again, none of 
the m utant viruses were detected by plaque assay o f lung homogenates. In  the 
liver o f infected animals, neither WT nor m utant MCMV was detected in  this 
experiment. Although the MCMV m utants did not replicate to detectable levels 
in the spleen, lungs, or liver of infected mice, the levels o f WT virus detected in 
these organs were too low to make any valid comparisons between WT and 
m utant MCMV growth. In  th is study, the animals were inoculated w ith  tissue- 
culture-passaged virus, which is greatly attenuated in vivo, and does not grow 
well in  most organs, w ith the exception o f the salivary gland (Jordan and 
Takagi, 1983; Osborn and Walker, 1970). Because the mutants grew so poorly 
in  the salivary gland, it  was not possible to obtain the more virulent salivaiy- 
gland-passaged viruses required for th is type o f experiment. As a result, 
conclusions concerning the growth o f these MCMV m utants in the spleen, liver, 
and lungs of infected mice cannot be made.
The growth of each m utant virus was also quantitated in  the footpads of 
mice inoculated subcutaneously in  the ir h ind footpads. This experiment was 
conducted to determine the feasibility o f examining the CTL response to each 
m utant in vivo, which is quantitated by lim iting  d ilu tion  analysis o f the popliteal 
lymph nodes draining infected footpads (Campbell et al., 1989). The lim iting 
d ilu tion analysis measures the frequency o f CTL precursors, present in  the 
lymph nodes o f inoculated mice, tha t were primed and activated in vivo in 
response to virus infection. However, p rio r to conducting this cumbersome 
analysis, it  was im portant to determine whether the virus mutants were capable 
of replicating in the tissues o f the footpad. Otherwise, a reduced CTL precursor
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frequency could be the result o f poor virus replication in  the footpad, thereby 
reducing the amount of antigen present, and would not accurately represent the 
immunogenicity of the m utants. Figure 14 illustrates tha t at 4 days post­
inoculation, the growth o f the m utant viruses in  the footpad was significantly 
lower than tha t of WT MCMV. Because a ll o f the m utants displayed 
significantly reduced growth in  footpad tissues, comparisons o f CTL precursors 
generated by WT virus and the RV m utants would not be valid.
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V. DISCUSSION
Nonessential MCMV genes are located in  the Hind III-J  and -I fragments 
In th is study, nonessential regions o f the MCMV genome were identified 
w ithin the Hind III-J  and -I fragments. More specifically, the right-m ost 4.7 kb 
o f Hind III-J  and the left-m ost 3.0 kb o f Hind III-I (sequences deleted in  RV7) 
are nonessential fo r virus replication in  tissue culture. The DNA sequences of 
the Hind III-J  (8.1 kb in  length) and -I (9.7 kb in  length) fragments have been 
obtained from the data base o f a current project to determine the complete DNA 
sequence of the MCMV (Smith) genome (Rawlinson et al., 1993). Previous 
transcript mapping experiments revealed tha t there is no immediate early 
transcription from the Hind III-J  and -I regions of the MCMV genome (Keil et al., 
1984). However, a t early and late times after infection, transcription from a ll of 
the Hind III fragments occurs (Keil et al., 1984).
RNA transcripts encoded w ithin the Hind III-J  fragment were identified 
by hybridizing infected cell RNA, isolated a t early or late times, w ith various 
probes prepared from th is fragment (Vieira et al., 1994). This region o f the 
MCMV genome was found to encode seven early transcripts and one late 
transcript, a ll o f which are transcribed in  the leftward direction (Thale et al., 
1994; Vieira et al., 1994). The DNA sequence o f the Hind III-J  fragment was 
then analyzed for the presence o f protein coding sequences containing in itia to r 
methionine codons whose context resembled the Kozak consensus sequence for 
translation in itia tion  (Kozak, 1989). Using th is criterion, seven open reading
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frames (ORF) were identified w ith in  Hind III-J , a ll o f them oriented in  the same 
leftward direction on the MCMV genome (shown in  Fig. 15). Because the 
sequence analysis o f the entire MCMV genome has not been completed, these 
ORFs have been temporarily designated HJ1 through HJ7 (for Hind III-J  1 
through 7).
To date, there have been no published reports o f fine RNA transcript 
mapping experiments using probes prepared from the Hind III-I region of the 
MCMV genome. Preliminary data o f some transcripts encoded w ith in  Hind III-I 
comes from the above described experiments o f transcript mapping using 
probes from  H ind III-J . From these studies (Thale et al., 1994; Vieira et al.,
1994), i t  is known tha t the start sites o f the early 4.1, 6.0, and 7.4 kb 
transcripts lie in  the adjacent Hind III-I fragment. The DNA sequence o f the 
entire Hind III-I fragment was analyzed by the method o f Fickett for the 
detection o f potential protein coding regions, or ORFs. The criteria used to 
select these potential ORFs were: (1) the presence o f an in itia to r methionine 
codon whose context sequence resembled the Kozak consensus sequence 
(RNNATGG) for translation in itia tion, (2) those tha t were oriented in the leftward 
direction on the v ira l genome, and (3) those that did not overlap any other 
potential ORF. The results o f th is analysis (shown in  Fig. 16) indicate that 
there are 6 potential ORFs encoded w ith in  Hind III-I. Open reading frames were 
chosen based on a leftward orientation because it  is known tha t the three 
largest transcripts mapped to Hind III-J  in itia te in  the adjacent Hind III-I 
fragment and are transcribed in  a leftward direction (Thale et al., 1994; Vieira et 
al., 1994). B ut u n til further transcript mapping experiments are conducted, it
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is not known if  any o f these represent bonafide ORFs. Nevertheless, it  can be 
concluded tha t the RV7 deletion removes the MCMV sequences encoding the 
early 1.3, 1.9, 4.1, 6.0, and 7.4 kb transcripts (see Figs. 15 and 16). In 
addition, the RV9 deletion may remove sequences encoding two more potential 
ORFs, one or both o f which may be essential for MCMV replication in vitro.
Recently, Mocarski and coworkers have constructed recombinant viruses 
cariying insertions which d isrupt each of the ORFs predicted to exist in  the 
Hind III-J  fragment (Cardin et al., 1993; Vieira et al., 1994). The growth 
kinetics o f a ll m utant viruses are the same as WT virus, demonstrating that a ll 
of the genes encoded in  the Hind III-J  fragment o f the MCMV genome are 
dispensable for growth in  cultured fibroblasts. W ith the exceptions o f the 
m utants disrupting the HJ1 and HJ2 ORFs, these MCMV m utants have not 
been evaluated in  the infected mouse, therefore the functions of these vira l 
genes in  vivo are not known.
The single late transcript, which begins in  Hind III-J  and crosses the 
Hind III-J /L  junction, contains the HJ1 ORF. MCMV m utants cariying 
insertions in th is ORF have been extensively studied in  the infected mouse, but 
have failed to identify a function for th is late gene in vira l replication, tissue 
tropism, or latency (Cardin et al., 1993).
The sggl gene includes the HJ2 and HJ3 ORFs, and encodes two 3’- 
coterm inal early transcripts o f 1.5 and 1.8 kb in  size (Lagenaur et al., 1994).
The more abundant 1.5 kb transcrip t contains the HJ2 ORF and encodes a 37 
kilodalton (kd) protein, designated Sggl. The 1.8 kb transcript initiates 
upstream o f the 1.5 kb transcrip t and contains the HJ3 ORF, in  addition to the
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HJ2 ORF. However, the HJ3 ORF is not translated, therefore th is longer 
transcript also encodes the 37 kd Sggl protein (Lagenaur et al., 1994). 
Recombinant viruses carrying m utations disrupting the expression of the Sggl 
protein grow very poorly in  the salivary glands o f inoculated mice, while growth 
in  the liver and spleen are not significantly affected (Manning et al., 1992).
Sggl-deficient viruses m aintain the ability to disseminate in  the infected mouse 
and to enter serous acinar epithelial cells, although they fa il to replicate 
efficiently in this cell type (Lagenaur et al., 1994). These results indicate that 
the sggl gene of MCMV is required for high levels o f vira l replication in the 
salivary glands. Incidentally, a ll o f the MCMV m utants constructed in th is 
study contain an in tact sg g l gene, yet fa il to replicate efficiently in  the salivary7 
glands of infected mice. These data indicate tha t there are other MCMV genes, 
in  addition to the sgg l gene, which influence vira l replication in  the salivary 
glands.
The fc r l gene o f MCMV includes the HJ6 ORF, and produces one early 
transcript of 1.9 kb, w hich encodes an Fc receptor for IgG (Thale et al., 1994). 
The products of the f c r l  gene are glycoproteins o f 86-88 and 105 kd, and 
represent homologs o f the gE proteins of three alpha-herpesviruses, HSV-1, 
varicella zoster virus (VZV), and pseudorabies virus (PRV) (Thale et al., 1994; 
Whealy et al., 1993). In  HSV-1, VZV, and PRV, the Fc receptors consist of a 
heterodimer o f the gE and gl proteins, both o f which are needed to bind IgG 
(Johnson et al., 1988; L itw in  et al., 1990). Whether the MCMV Fc receptor is 
composed of a sim ilar heterodimer is unknown at the present time. Although 
HCMV also expresses an Fc receptor for IgG, there is no homologue of the f c r l
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gene found in  the HCMV genome (Thale et al., 1994). At present, MCMV 
m utants deleted o f the f c r l  gene have not been evaluated in a mouse model, 
therefore, the functional relevance o f th is  gene product during MCMV infection 
is unknown. In  a ra t model o f PRV infection, the gE-gl heterodimer is required 
for the transneuronal transport o f virus from the retina to several regions o f the 
brain (Whealy et al., 1993). Thus, eventhough gE and gl are both nonessential, 
they function in  concert to affect neurotropism o f PRV in  the ra t brain.
Presently, a gl homologue has not been identified in  MCMV. Nonetheless, it  is 
possible tha t MCMV gE, acting alone or in  conjunction w ith other vira l proteins, 
may influence tropism to macrophages. Another hypothesis, which is 
supported by in  vitro data, is tha t this Fc receptor functions to modulate the 
activity of virus-specific antibodies. For example, the HSV-1 Fc receptor is 
capable of antibody bipolar bridging of antiv ira l IgG molecules (Frank and 
Friedman, 1989). This refers to the binding o f a single IgG molecule (directed 
against HSV-1 gC or gD) by its  Fab end to gC or gD, while the Fc end o f the 
same molecule binds to the HSV-1 Fc receptor. By engaging the Fc end of 
antivira l IgG, HSV-1 resists antibody- and complement-dependent 
neutralization. Alternatively, the Fc binding activity of the f c r l  gene product 
may be irrelevant to its in vivo function, and may instead indicate a propensity 
o f this molecule to interact w ith other proteins. In fact, in vivo studies 
conducted in  immunoglobulin-deficient mice indicate that the absence of 
antibodies does not alter the course and the kinetics of primary MCMV infection 
(Jonjic et al., 1994). In th is study, the RV6 deletion includes the entire HJ6
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ORF, however, the phenotype o f this m utant cannot be solely attributed to the 
lack o f the fc r l  gene, because the deletion also includes most o f the HJ5 ORF.
The remaining transcripts encoded in  the Hind III-J  fragment of the 
MCMV genome are uncharacterized in terms o f the protein products they 
encode and their functions during infection. Three o f the larger early 
transcripts (the 4.1, 6.0, and 7.4 kb transcripts) are predicted to in itia te in  the 
adjacent Hind III-I fragment. The deduced amino acid sequences encoded by 
the seven ORFs in  Hind III-J  were screened by computer analysis to determine 
i f  they possessed homology to any HCMV ORFs, and only one product was 
found to exhibit significant sim ilarity. The product of the HJ7 ORF possesses 
homology w ith the US22 gene fam ily of HCMV (Vieira et al., 1994). The US22 
gene family of HCMV consists o f 13 ORFs, one o f which encodes the 
nonessential IRS1 gene (Chee et al., 1990) (see Fig. 2). This protein has 
transcriptional transactivating activities, and is believed to cooperate w ith the 
IE1 and IE2 proteins of HCMV to activate other vira l promoters (Stasiak, 1991). 
I f  the protein encoded by the MCMV HJ7 ORF, which is deleted in  RV7, has 
sim ilar transcriptional transactivating capabilities, then perhaps the defects 
displayed by th is m utant virus (poor growth in  macrophages, and inability to 
grow in  salivary glands) may be due, in  part, to the absence o f such a 
transactivator. There are no homologues to HCMV in either the nucleic acid 
sequences of Hind III-I (Rawlinson et al., 1993) or in  the deduced amino acid 
sequences encoded by the six potential ORFs in  Hind III-I.
Collectively, the MCMV m utants created by Mocarski and his colleagues 
demonstrate tha t a ll o f the vira l genes encoded w ithin Hind III-J  are
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nonessential. However, a function for only one of these gene products, the Sggl 
protein, has been identified in  vivo (Lagenaur et al., 1994; Manning et al., 1992). 
In addition, a ll o f the m utants created by th is group consist o f insertions or 
small deletions which d isrupt the expression o f only one v ira l gene product in 
each mutant. In contrast, the virus m utants generated in  th is  study cany' large 
deletions, spanning up to 10.7 kb o f MCMV sequences, and are predicted to 
d isrupt the expression o f m ultiple MCMV genes simultaneously. This may 
become im portant in  identifying phenotypes for these m utants. Because the 
MCMV genome is estimated to contain 200 genes (Rawlinson et al., 1993), any 
one o f these vira l genes, by itself, may be expected to play a subtle role during 
vira l pathogenesis. Or, perhaps two or more vira l genes act together to 
influence a particular aspect of pathogenesis. Therefore, identifying a function 
for any one o f these genes, by itself, may be d ifficu lt. And indeed, th is appears 
to be the case w ith some o f Mocarski’s MCMV mutants. Extensive in vivo 
evaluations o f those m utants disrupted in  the IE2 gene or in  the late gene 
encoded at the Hind III-L /J  junction have failed to identify functions for these 
genes in the infected mouse (Cardin et al., 1993). Although it  is possible that 
MCMV evolved to carry’ genes that are unnecessary, it  is more likely that the 
correct experimental conditions required to observe the true functions of these 
genes have not been found.
From Figure 15, it  is predicted tha t the m utation in  RV5 may disrupt the 
expression o f four RNA transcripts: the in itia tion  o f the early 1.9 kb transcript 
encoding the Fc receptor, and the polyadenylation o f the 4.1, 6.0, and 7.4 kb 
transcripts. The deletion constructed in  RV6 deletes two ORFs, HJ5 and HJ6,
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and deletes the polyadenylation signal for the three largest transcripts mapped 
to the Hind III-J  region. The deletion in  RV7 deletes three ORFs in H ind III-J , 
namely HJ5, HJ6, and HJ7, and also deletes the region in  Hind III-I from which 
the three larger transcripts are produced (see Fig. 16). W ith the exception of the 
Fc receptor, nothing is known o f the gene products encoded by these 
transcripts. A t present, it  is unclear whether the RV5 insertion significantly 
affects the synthesis, structure, or function o f any o f these vira l gene products. 
However, m utant viruses RV6 and RV7 lack the vira l sequences encoding 
m ultiple RNA transcripts, and are therefore defective in the production o f 
several MCMV gene products.
The helper-dependence o f RV9 indicates that the deletion constructed in 
th is m utant extends into an essential region of the MCMV genome. Therefore, 
an essential gene or genes required for MCMV replication in cultured fibroblasts 
resides w ith in  the 3.0 kb o f Hind III-I sequences deleted in  RV9 but present in 
RV7. Alternatively, it  is possible that th is region carries one copy o f an 
essential gene product present in  duplicate copies in  the Hind III-J  and -I 
fragments o f the MCMV genome. In th is case, the deletion of one copy o f the 
gene is not detrimental, but the deletion o f both copies (possibly occuring in 
RV9) is lethal. Because many herpesviruses, including HCMV and HSV, consist 
o f two sets o f unique sequences (Us and Ul) each flanked by repeated sequences 
(see Fig. 1), genes mapping to these repeated sequences are present in  two 
copies per v ira l genome. Although the MCMV genome contains no repeated 
DNA sequences, redundant MCMV genes may s till exist, i f  not in  sequence, 
then possibly in  function.
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Nonessential MCMV genes within Hind III-J  and -I are not involved in MHC
class I expression
The MCMV sequences identified as nonessential w ith in  H ind III-J  and -I 
are not involved in the down-regulation o f MHC class I expression observed in 
infected cells. In itia lly , th is finding was surprising, since the corresponding 
region of the HCMV genome, specifically the US2-5 and US11 loci, are involved 
in  class I reduction in  infected human cells (Jones et al., 1995). However, upon 
more careful consideration, th is  result was not so unexpected.
Eventhough the MCMV and HCMV genomes show significant sequence 
homology and a colinear arrangement o f many genes, these sim ilarities apply 
prim arily to essential genes (Messerle et al., 1992; Mocarski et al., 1990; 
Rawlinson et al., 1993). In  general, essential genes w ith  critica l functions, 
including the major IE proteins (IE1 and IE3 o f MCMV, and IE1 and IE2 of 
HCMV), the DNA polymerase, the MDBP, the ICP18.5 homolog, and the gB 
protein, display high degrees o f amino acid sequence homology between the 
viruses. In addition, these essential genes are organized in  exactly the same 
order along the vira l genomes, and show sim ilar map positions. However, 
outside of these conserved blocks of homologous essential genes, the MCMV 
and HCMV genomes show very little  homology. In fact, the Hind III-J  and -I 
fragments of the MCMV genome show only marginal sim ilarity to any portion of 
the HCMV genome (Rawlinson et al., 1993; Vieira et al., 1994).
Because th is region o f the MCMV genome, and the corresponding region 
o f the HCMV genome, are nonessential, they are predicted to im pact on the 
interaction of the virus w ith  its  host. These nonessential regions of the MCMV
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and HCMV genomes are divergent, probably because they coevolved separately 
w ith in  the ir respective hosts for a period o f 30 m illion years (H ill and Ploegh,
1995). During this evolutionary process, MCMV evolved the means to inh ib it 
the antigen presentation system present in  the mouse, and HCMV evolved 
mechanisms to interact w ith  the antigen presentation system present in  the 
human. Indeed, both viruses prevent class I molecules from leaving the 
endoplasmic reticulum  (ER), however, the mechanisms utilized by the viruses 
are quite different. In  MCMV-infected cells, class I molecules are loaded w ith 
peptide, bu t remain trapped in  the ER, where they accumulate (Del Val et al., 
1992). In  addition, there is a defect in  the synthesis of class I molecules in 
MCMV-infected cells (Campbell et al., 1992 and 1994). In  HCMV-infected cells, 
conformationally in tact MHC class I molecules are assembled, however, they 
are unstable and are rapidly degraded shortly after the ir synthesis (Beersma et 
al., 1993; Warren et al., 1994). In  addition, the HCMV-induced instability in 
class I assembly is specific for human class I molecules. In  murine fibroblasts 
transfected w ith a human class I molecule, human leukocyte antigen B27 (HLA- 
B27), HCMV infection specifically decreased the expression of HLA-B27, but 
had no effect on the expression o f the endogenous murine H-2Kk molecules 
(Beersma et al., 1993). In a recent review article (1995), H ill and Ploegh wrote 
the ir opinions concerning th is divergent evolution of MHC class I inh ib ition by 
different viruses:
“We see th is interaction between the evolution o f antigen presentation 
and viral-evasion mechanisms as rather like a prolonged chess game between 
well-matched players. From the same starting point, different paths are
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followed, depending on the moves of the opponent. It is clear tha t the evolution 
o f class I-restricted antigen presentation has affected the evolution o f the 
viruses..., and we contend that the particu lar viral-evasion strategies developed 
have, in  turn, influenced the evolution o f antigen presentation w ith in  each 
species.”
As a note, prelim inaiy data indicate tha t an MCMV gene influencing 
MHC class I transport lies in the Hind III-E  fragment o f the viral genome 
(Koszinowski, personal communication), and another vira l gene involved in the 
inh ib ition  o f antigen presentation to CTLs is located in  the Hind III-A  fragment 
(Hill, personal communication).
Nonessential regions of Hind III-J  and -I are required for efficient MCMV 
replication in  the salivary glands
Nonessential regions of MCMV Hind III-J  and -I identified in  th is study 
are required for efficient viral replication in  the salivaiy gland, an organ central 
to the biology of CMV. None o f the MCMV m utants tested in  th is study grew as 
well as WT MCMV in  the salivaiy glands o f infected mice.
The replication of RV5 in  the salivary glands of inoculated animals was 
slightly less than tha t of the WT virus. RV5 reached a peak tite r of 
approximately 105 PFU per m l o f organ homogenate, one or two logs less than 
tha t o f WT MCMV. Thus, it  appears tha t the insertion created in th is m utant 
virus disrupts the expression o f an MCMV gene, or genes, influencing salivaiy 
gland growth. The lack of this gene product, either directly or indirectly, results 
in  a slightly reduced ability o f the virus to replicate in  the salivary gland. This 
finding can be interpreted in one o f three ways. First, it  is possible tha t the
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m utation does indeed disrupt an MCMV gene directly involved in  viral 
replication in  the salivaiy gland. This gene product could represent a tissue- 
specific factor required for efficient MCMV entry into or growth in  salivary gland 
serous acinar epithelial cells. However, th is factor does not represent a critical 
or pivotal factor, because the efficiency in  replication is only slightly reduced. 
More appropriately, it  may represent an “accessory” factor for salivaiy gland- 
specific growth.
Secondly, the m utation may not encode a factor specific for salivaiy 
gland growth, bu t instead, may encode a general factor required for efficient 
growth in  a ll organs o f the infected mouse. In  other words, the vira l gene 
product indirectly influences salivaiy gland growth, inasmuch as its absence 
decreases the efficiency of MCMV replication in  vivo. For example, th is gene 
may encode a vira l determinant fo r entry, dissemination, or growth in vivo. Or, 
it  may encode a regulatory protein tha t influences the synthesis o f proteins 
expressed from other viral genes required for efficient MCMV replication in any 
organ, not ju s t in  the salivaiy gland. In th is example, the missing gene product 
would function nonspecifically to reduce replication in  the salivaiy gland, and 
would not represent a true determ inant of v ira l growth in th is organ. I f  this 
were the case, then RV5 would also exibit poor growth in  a ll other organs of 
infected mice. Unfortunately, conclusions concerning growth in  these other 
organs cannot be made in th is  study.
Lastly, it  is possible tha t the reduced tite r o f RV5 in the salivary gland is 
not the result o f an MCMV gene disruption, bu t instead is due to the expression 
o f the P-glu gene. Mocarski and his coworkers have observed tha t every one o f
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their lacZ-tagged MCMV m utants evaluated in vivo, regardless o f the insertion 
site, has exibited th is organ-specific reduction in  peak titers. In  addition, the ir 
lacZ-insertion mutants exibited sim ilarly reduced growth patterns in  the 
salivaiy glands o f immunodeficient mice (nude and SCID), indicating tha t an 
immune reponse to the p-gal protein (encoded by the lacZ gene) did not cause 
the lower virus yeilds. W ith many o f these mutants, reduced growth was not 
observed in  any other tissues o f infected mice, only in  the salivaiy gland. These 
data suggest tha t the expression o f p-gal results in  lower virus titers specifically 
in  the salivaiy gland, by an unknown mechanism. I t  is possible tha t the 
expression o f P-glu in  our mutants may cause a sim ilar reduction in  salivaiy 
gland growth.
The replication of RV6 in  the salivaiy glands o f inoculated mice was 
significantly reduced, only reaching peak titers of 103 PFU per m l o f tissue 
homogenate, which is 4 logs lower than tha t o f WT MCMV. This m utant is 
probably defective in  the expression o f m ultiple MCMV gene products, and as a 
result, replicates poorly in  the salivaiy gland. Again, there are several 
possibilies to explain th is phenolype. The salivaiy gland plays a central role in 
MCMV biology, and there are probably many vira l genes which function to 
control tropism  to , persistent growth in, and shedding from th is tissue. The 
deletion o f only one of these genes may result in  slightly reduced salivaiy gland 
titers, such as that observed for RV5. However, the deletion o f m ultiple genes 
influencing salivary gland growth may result in  poor replication in  th is organ, 
such as tha t observed for RV6 and RV7. This study clearly demonstrates tha t 
the more extensive the mutation to the MCMV genome, the poorer the ab ility  of
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the m utant virus to replicate in  the salivaiy gland. These data indicate that 
there are many vira l genes influencing salivaiy gland growth, and tha t the 
effects o f deleting increasing numbers o f these genes on reducing virus growth 
in  th is  tissue may be additive.
Another possibility, like tha t for RV5, is tha t the vira l sequences deleted 
in  RV6 encode general replication factors required fo r the efficient growth of 
MCMV in vivo. The deletion o f two or more o f these factors (possibly occuring in  
RV6) would result in  lower virus titers in vivo than would be observed i f  only one 
of these factors were missing (possibly occuring in  RV5). However, since 
attenuated virus (tissue-culture-passaged) was used in  our in vivo analyses, 
neither WT MCMV nor any of the MCMV m utants grew efficiently in  other target 
organs o f infected mice. Therefore, determinations o f WT or m utant virus 
growth in  the spleen, liver, or lungs o f infected animals cannot be made in  this 
study. Regardless, i t  is clear tha t RV6 grows as efficiently as WT MCMV in 
vitro, bu t grows poorly in  the salivary glands of infected animals, and is 
therefore lacking gene products needed for efficient MCMV replication in  the 
salivaiy glands. As a consequence, th is MCMV m utant would also be expected 
to exhibit significantly reduced virus tite rs in  saliva, and greatly reduced 
transmission capabilities as compared to WT MCMV.
The replication o f RV7 in  the salivaiy glands o f inoculated mice was 
dramatically reduced to levels that were barely detectable. This finding strongly 
suggests that m ultiple MCMV genes are involved in salivaiy gland growth, 
either directly or indirectly. Presumably, the progressive reduction in  salivaiy 
gland tite rs observed w ith  the m utants in  th is study results from the increasing
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number o f MCMV genes tha t are disrupted. Whether these genes are involved 
in  growth specific to the salivaiy gland, or in  general vira l replication w ith in  the 
mouse, cannot be determined at th is time. Nevertheless, the genes deleted from 
RV7 are necessary for MCMV replication in  the salivaiy glands o f infected mice, 
eventhough they are not required for virus growth in  cultured fibroblasts.
It is possible tha t one or more o f the genes missing in  RV7 provide 
specialized functions tha t are absolutely required for MCMV growth in  acinar 
cells of the salivaiy gland. The localization o f MCMV to serous acinar epithelial 
cells and HCMV to ductal epithelial cells indicates that the viruses differ w ith 
respect to tropism  for particular subsets o f epithelial cells present in  the 
salivaiy gland. Perhaps a gene product m issing in  RV7 encodes an MCMV 
determinant governing tropism to this type o f epithelial cell, such as an 
envelope glycoprotein necessary for attachment or penetration.
The drastically reduced growth o f RV7 in  the salivaiy glands is probably 
not the result o f a defect for growth in prim aiy murine cells per se, because this 
m utant replicated as well as WT MCMV in  prim aiy embiyo fibroblasts (derived 
from BALB/c mice, the same strain used in  our in vivo experiments). More 
likely, RV7 may be defective for growth in  epithelial cells. In vivo, MCMV 
characteristically infects epithelial cells, however, prim aiy epithelial cell lines 
are currently not available to test this hypothesis.
Because RV7 displayed a defect in  macrophage-specific growth 
(discussed in more detail in the following section), perhaps dissemination to the 
salivaiy gland may be compromised by the RV7 m utation. However, th is defect 
would not totally explain the lack o f growth o f RV7 in  th is organ. In Figure
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13B, RV7 can be detected in  the salivaiy glands a t 50 PFU/m l of homogenate, 
on day 14 post-inoculation. This indicates tha t the m utant did reach the 
salivaiy gland. But, once reaching th is organ, it  did not replicate well there, 
and could not be detected a t any other time point thereafter. I f  the problem 
was prim arily dissemination, then once the virus reached the salivary gland, 
growth levels sim ilar to WT levels should be observed. Thus, poor 
dissemination may have contributed to, but was not the prim aiy reason for, 
poor growth in  the salivary gland.
The failure of RV7 to grow in the salivaiy glands o f inoculated mice is not 
the result o f an immune response to the P-glu protein. RV5 and RV6, which 
also express P-glu, displayed much higher titers in  the salivaiy gland. In 
addition, experiments conducted by a collaborating laboratoiy (Dr. Herbert 
Virgin, Washington University, St. Louis, MO) reveal tha t RV7 exhibited 
undetectable growth (less than 4 PFU/m l o f tissue homogenate) in  the salivaiy 
glands of SCID mice, which lack a functional immune system.
RV7 also failed to replicate to detectable levels in  the spleen and liver of 
inoculated SCID mice (Virgin, personal communication). In  these 
immunodeficient animals, WT MCMV replication is never brought under 
control, even w ith  tissue-culture-passaged virus. Inoculated animals succumb 
to as little  as 2 to 3 PFU o f WT virus by 18 to 20 days post-inoculation (Pollack 
and Virgin, 1995). Therefore, these mice are veiy sensitive indicators for 
infectious MCMV. The failure of RV7 to replicate in these immunodeficient 
mice, strongly suggests th a t RV7 is incapable o f in  vivo growth. Thus, it
83
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
appears that the v ira l gene products missing in RV7-infected cells are necessary 
to carry out the events required for MCMV replication in vivo.
Nonessential MCMV genes encoded w ith in  Hind III-J  and -I are involved in
macrophage-specific growth 
MCMV genes encoded w ith in  the nonessential regions o f Hind III-J  and -I 
are also involved in  macrophage-specific growth, because the deletion o f these 
sequences results in  greatly reduced replication in  macrophages. Interactions 
between the virus and monocytes/macrophages have been viewed as critica l to 
MCMV biology, particularly in  dissemination and latency. Peripheral blood 
monocytes are the only blood cell type which are fu lly permissive for MCMV 
replication (Collins et al., 1994), and are involved in disseminating MCMV from 
sites o f in itia l replication to a ll other organs o f the infected animal (Stoddart et 
al., 1994). In addition, the monocyte harbors latent virus genomes (Mocarski et 
al., 1990), and probably represents the source of virus spread in blood 
transfusions from healthy sero-positive individuals (Kondo et al., 1994).
In  IC-21 cells, a fully-differentiated macrophage cell line, RV7 grew 2 to 3 
logs less than tha t o f WT MCMV, whereas RV6 grew sim ilarly to the WT virus. 
Therefore, the genes influencing macrophage-specific growth are located w ith in  
the right-m ost 1.9 kb o f Hind III-J  and the left-most 3.0 kb o f Hind III-I. 
Additional studies in  our laboratory using several o f the Mocarski insertion 
m utants in  Hind III-J  (described in Vieira et al., 1994) confirm tha t the deletion 
in  RV7 is unique in  ablating virus growth in  macrophages. In  fact, each o f the 
Hind III-J  insertion m utants tested grew sim ilarly to WT MCMV in IC -21
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macrophages, indicating that the MCMV sequences contained w ith in  the left­
most 3.0 kb o f H ind III-I are responsible for th is  phenotype.
The viral genes involved in  macrophage-specific growth act following vira l 
penetration, during the immediate early phase o f MCMV replication. 
Transcription of the IE1 gene was significantly reduced by 8- to 9-fold in  RV7- 
infected IC-21 macrophages. This IE gene is essential for MCMV replication. 
Several attempts to construct IE1 insertion m utants have failed (Mocarski et al., 
1990), and transient transactivation experiments in  murine fibroblasts have 
ascribed im portant regulatoiy functions to the IE1 gene product (Keil et al.,
1985 and 1987). It  appears tha t the IE1 and IE3 gene products act 
synergistically for maximal transactivation o f vira l gene expression. 
Consequently, reduced IE1 levels would result in  greatly reduced subsequent 
vira l gene expression, and greatly reduced virus yeilds. Indeed, this appears to 
be the sequence o f events in RV7-infected IC-21 macrophages. Following 
reduced IE1 gene expression, the levels of the e l early transcript and the gB 
late transcript are also significantly reduced. These data correlate w ith the 
decreased virus yeilds from these macrophages.
There are differences in  the regulation o f the immediate early phases of 
HCMV gene expression in  fibroblasts versus macrophages (Keny et al., 1995).
A 1.4 kb mRNA from  the major IE gene region o f HCMV was not detectable 
during a normal infection of human fibroblasts, bu t was readily detected in 
infected human macrophages a t immediate eaiyl times. These results suggest 
tha t th is IE gene product exhibits cell type-specific expression, and may be 
im portant in the regulation o f HCMV infection in  macrophages. Perhaps the
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m utation in  RV7 deletes an MCMV homologue to th is HCMV IE gene product, 
and thereby blocks the course o f subsequent v ira l gene expression in  murine 
macrophages, bu t has no effects on gene expression in  fibroblasts.
It  is also possible tha t a host factor present in  fibroblasts, but absent in  
macrophages, can functionally compensate for the missing vira l gene products 
in  RV7. For example, herpesviruses in  general encode many o f the enzymes 
required for vira l DNA synthesis, and most o f these enzymes are counterparts of 
cellular enzymes, but have different substrate specificities and regulatory 
properties (Roizman et al., 1987). Some host enzymes can complement, in  part, 
vira l requirements for these functions. And some HSV-1 m utants grow better in 
some cell lines than in  others (Roizman et al., 1985).
An intriguing possibility is that the deletion in  RV7 encodes a virion 
structura l protein, such as a tegument protein, which is delivered into the cell 
upon virus penetration and functions to enhance immediate early transcription 
in  macrophages, but is not necessary for immediate early transcription in 
fibroblasts. Although th is possibility is purely speculative, both HCMV and 
HSV encode tegument proteins tha t enhance immediate early transcription in  
permissive cells (Liu and Stinski, 1992; Roizman, 1990b). And yet another 
possibility is tha t the DNA sequence deleted in RV7 contains an enhancer 
region required for efficient immediate early transcription in  macrophages, but 
not needed for immediate early transcription in  fibroblasts. The promoter for 
the major IE genes of MCMV, IE1 and IE3, is located in  relatively close 
proxim ity to the RV7 deletion, less than 7 kb downstream (leftward on the 
MCMV genome).
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In  summary, the salivaiy gland and the macrophage play key roles in 
MCMV pathogenesis. The failure o f RV7 to replicate in  the salivary glands, and 
its  greatly reduced ability to replicate in  macrophages, strongly suggest that the 
MCMV sequences deleted in  th is  m utant are crucial fo r MCMV pathogenesis in  
vivo, particularly in virus growth, persistence, transmission, dissemination, and 
latency.
Continued studies include finer deletion mapping o f the Hind III-I region 
by constructing additional m utants containing deletions o f subregions o f the 
RV7 deletion. In  th is way, MCMV sequences involved in  macrophage-specific 
growth and salivaiy gland-specific growth can be better defined. Future studies 
also include transfecting NIH3T3 fibroblasts w ith the middle 3.0 kb Sst I 
fragment o f Hind III-I, which encodes an essential gene for MCMV replication in  
vitro, and infecting these cells w ith  RV9. The stably integrated MCMV DNA 
fragment should provide the essential gene product in  trans, and the isolation of 
a pure RV9 stock should be possible. This m utant can then be analyzed to 
identify the essential MCMV gene product(s).
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FIGURE 1. A schematic diagram o f the sequence arrangements in  the HCMV 
and MCMV genomes. In the HCMV genome, DNA sequences from both term ini 
are repeated in  an inverted orientation and positioned side-by-side internally, 
dividing the genome into two components o f unique sequences, Us and U l ,  each 
flanked by inverted repeats. The MCMV genome consists entirely o f unique 
DNA sequences. U l  and Us, unique sequences o f the long and short 
components, respectively; T R l  and TRs, term inal repeat sequences o f the long 
and short components, respectively; I R l  and IRs, inverted repeat sequences o f 
the long and short components, respectively.
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TABLE X. Nonessential viral genes tha t are known to, or are predicted to, 
influence pathogenesis in vivo. These examples were compiled from: Gooding, 
1992; Johnson et al., 1995; Jones et al., 1995; McCance et al., 1995; Symons 
et al., 1995. Abbreviations: Ad, adenovirus; EBV, Epstein-Barr virus; elF, 
eukaryotic translation initia tion factor; IFN, interferon; IL, interleukin; HCMV, 
human cytomegalovirus; HSV, herpes simplex virus; HPV, human 
papillomavirus; MHC, major histocom patibility complex; TNF, tum or necrosis 
factor.
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TABLE 1. Nonessential V ira l Genes that Modulate
Pathogenesis
Virus Fam ily Virus Gene Product Function
Adenoviruses Ad2 E3-gpl9k reduces MHC class I
E3-14.7k inhib its TNF-mediated lysis
E3-10.4/14.5k inhib its TNF-mediated lysis
A d l2 E1A inhib its MHC class I mRNA
Poxviruses Myxoma T2 inhib its TNF
Vaccinia C21L inhibits complement
B15R inhib its IL -ip
E3L inhib its IFN-a/p
IFN-yR inhib its IFN-y
K3L inhib its eIF2a
Herpesviruses EBV EBER RNA inhib its IFN-a/p
BCRF1 IL-10 homologue
HCMV US2-5 reduces MHC class I
US11 reduces MHC class I
HSV-1/2 gC-1 inhibits complement
gE-gl inh ib its antibody neutralization
ICP47 reduces MHC class I
Papillomaviruses HPV-16 E5 reduces MHC class I
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FIGURE 2. (A) Schematic o f the w ild-type Sm ith stra in  MCMV genome, w hich is  230 kilobase pairs in  length. (B) 
Expansion o f the H ind III-J  and -I regions, showing the locations o f H ind III (H) and Sst I (Ss) sites, and fragm ent sizes 
in  kilobase (kb) pairs. (C) Locations o f the nonessential HCMV genes (IRS1 and US1 through US13 o f the AD169 strain) 
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FIGURE 4. Organizations o f plasmids used to generate MCMV recombinant 
viruses. (A) Plasmid pe l/P -g lu  carries an Sst I to Nco I fragment (0.2 kilobase 
[kb] pairs) from  the MCMV early region 1 (el) promoter (indicated as a stippled 
box) coupled to the Nco I to Sst I fragment (2.2 kb) o f the p-glu gene (indicated 
as the hatched rectangle). This 2.4 kb e l/p -g lu  cassette was cloned into the 
Sst I site o f the plasmid vector pGEM-7Z (indicated as solid rectangles). (B) 
Plasmid p3.4 jpglu contains the firs t 3.4 kb o f MCMV Hind III-J sequences 
(illustrated as an open rectangle) coupled to the e l/p -g lu  cassette. The solid 
rectangles represent vector sequences o f the pGEM-4Z plasmid. (C) 
Organization o f recombination plasmids. The th in  horizontal lines represent an 
expansion o f the MCMV Hind III-J  and -I fragments (indicated by opposing 
arrows), showing restriction endonuclease sites for Bgl II (B), Hind III (H), and 
Sst I (S), as well as the distance between these sites (indicated in kb). The 
vertically slanted lines illustrate those MCMV sequences (shown as open 
rectangles) used to construct the indicated recombination plasmids. Vector 
sequences o f pGEM-4Z are shown as solid rectangles. Recombination plasmid 
p jpg lu-5 carries the e l/P -g lu  cassette inserted at the second Sst I site in  Hind 
III-J. The remaining recombination plasmids were constructed using p3.4jpglu 
opened at the 3’ end o f the p-glu gene. To construct p jpg lu-6, the 1.9 kb Sst I 
fragment o f H ind III-J  was cloned behind the cassette. To create pJiPglu-7, the 
middle 3.0 kb Sst I fragment o f Hind III-I was cloned behind the cassette. To 
generate pJiPglu-9, the 3.7 kb Sst I fragment of H ind III-I was cloned behind 
the cassette.


























FIGURE 5 . Transfection o f MCMV DNA results in  productive infection. Various am ounts o f purified MCMV DNA (1, 2, 
3, 4, or 5 pg) were transfected into  NIH3T3 fibroblasts using a modified calcium  phosphate precip itation technique. A 
to ta l o f 7 pg o f DNA (MCMV DNA and ca lf thym us DNA, as a carrier) was transfected in to  3 X 106 cells in  suspension 
and placed in to  a 100-mm tissue cu ltu re  plate. The cells were shocked w ith  20% dim ethyl sulfoxide a t 5 hours post­
transfection, and then were overlayed w ith  0.5%  agarose the follow ing day. One week later, the cell monolayer was 









































FIGURE 6 . Insertion and deletion m utants o f the MCMV H ind III-J  and -I fragments. The e l/p -g lu  cassette, illustra ted  
as a stippled rectangle, was inserted a t the second Sst I site w ith in  MCMV H ind III-J  to generate recom binant v irus 5 
(RV5). RV6, RV7, and RV9 are deletion m utants in  w hich the hatched areas represent the locations o f MCMV genomic 
sequences th a t were deleted and replaced w ith  the e l/p -g lu  cassette. The numbers follow ing each rectangle indicate the 
sizes o f the e l/p -g lu  cassette (stippled rectangle) o r o f the deletions (hatched rectangles) in  kilobase (kb) pairs. H 
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FIGURE 7. Southern b lot analyses o f recombinant MCMV. DNA was isolated 
from NIH3T3 cells tha t were mock-infected (M), or infected w ith  wild-type (WT) 
virus or the indicated recombinant virus (RV) for 24 hours. The DNA was 
digested w ith  Hind III + Bgl II, or w ith Bgl II alone, and was analyzed by 
Southern blot. DNA probes o f MCMV Hind III-J  (J), H ind III-I (I), and the p- 
glucuronidase (P-glu) gene were labeled w ith DIG-dNTP using the random 
primed method. Hybridization was visualized by chemiluminescent detection 
using the Boehringer Mannheim Genius System. For RV5 and RV6, the odd- 
numbered lanes indicate digestion w ith Hind III + Bgl II, and the even- 
numbered lanes indicate digestion w ith Bgl II alone. For RV7 and RV9, the 
infected cell DNAs were digested w ith Hind III + Bgl II. For RV7, lanes 3 and 4 
represent DNA isolated from cells infected w ith independent isolates o f this 
m utant, and lane 5 represents the recombination plasmid used to generate 
RV7. RV9-infected cell DNA is represented in  lane 7, and its  recombination 
plasmid in  lane 8. Sizes of the DNA fragments are indicated in  kilobase (kb) 
pairs.
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TABLE 2. Hybridizing DNA fragments expected in  Southern blot analyses of 
MCMV mutants. Fragment sizes resulting from digestion o f infected cell DNAs 
w ith  the indicated restriction endonucleases and hybridization w ith  the 
indicated probes are listed in  kilobase (kb) pairs. Sizes were determined from 
the restriction endonuclease map o f the MCMV Hind III-J  and -I regions (see 
Figs. 3 and 4). The e l/p -g lu  cassette is 2.4 kb in length, and does not contain 
any sites for either H ind III or Bgl II.
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Southern Blot Analysis - Sizes of Expected Bands in Kilobase Pairs
Virus Probe Digestion of DNA 
w ith Hind II I  + Bgl n
Digestion of DNA with 
BglH
WT J 2.0, 2.8, 3.3 2.0, 2.8, 5.1
MCMV I 1.0, 1.7, 2.8, 4.2
RV5 J 2.0, 2.8, 5.7 2.0, 2.8, 7.4
P-glu 5.7 7.4
RV6 J 2.8, 4.9 2.8, 6.7
p-glu 4.9 6.7
J 2.8, 6.0
RV7 I 1.0, 2.7, 6.0
p-glu 6.0
J 2.8, 4.0
RV9 I 2.7, 4.0
p-glu 4.0
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FIGURE 8 . In  intro growth o f MCMV m utants in  fibroblasts. M ulti-step growth curves o f each recom binant virus (RV) 
were determ ined in  NIH3T3 fibroblasts (A) and in  prim ary embryo fibroblasts (B). Tissue cu ltu re  flasks (25 cm2) were 
seeded w ith  5 X 105 cells in  5 m l o f media. The follow ing day, the cells were infected w ith  w ild-type (WT) v irus o r the 
indicated m utant virus (RV) a t a m u ltip lic ity  o f 0.1 plaque-form ing un its  (PFU) per cell. A t the indicated tim es post­
infection, to ta l v irus was harvested and titered by standard plaque assay on NIH3T3 cells. Bach datum  po in t 
represents the average o f two separate cultures, and the standard deviation o f the geometric mean is  indicated by the 
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FIGURE 9. In  intro growth o f MCMV m utants in  macrophages. M ulti-step (A) and one-step (B) growth curves o f each 
recom binant v irus (RV) were determ ined in  1C-21 macrophages. Tissue cu lture  flasks (25 cm2) were seeded w ith  1 X 106 
cells in  5 m l o f media. The follow ing day, the cells were infected w ith  w ild-type (WT) v irus or the indicated m utant (RV) 
a t a m u ltip lic ity  o f 0.1 plaque-form ing un its  (PFU) per cell (for the m ulti-step growth curves), o r 5 PFU per cell (for the 
one-step growth curves). A t the indicated times post-infection, to ta l v irus was harvested and titered by standard plaque 
assay on NIH3T3 cells. Each datum  po in t represents the average o f two separate cu ltures, and the standard deviation 
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FIGURE 10. Northern b lo t analyses o f immediate early (IE), early (E), and late 
(L) RNAs from RV7-infected cells. Tissue culture plates were seeded w ith  2 X 
106 NIH3T3 or IC-21 cells. The following day, the cells were mock-infected (M), 
or were infected w ith  wild-type (WT) virus or the indicated recombinant virus 
(RV) at a m u ltip lic ity o f 4 plaque-forming units (PFU) per cell. Total RNA was 
isolated from infected cells under immediate early, early, or late conditions 
(using the Qiagen RNeasy Kit), and was hybridized to probes of known IE, E, or 
L genes, respectively. IE RNA was isolated at 3 hours post-infection, and was 
hybridized to a probe o f the MCMV Hind III-L  fragment (containing the IE1 and 
IE2 genes). E RNA was isolated at 24 hours post-infection in  the presence of 
phosphonoacetic acid (250 pg/m l), and was hybridized to a probe o f the early 
region 1 (el) gene. L RNA was isolated at 24 hours post-infection, and was 
hybridized to a probe of the glycoprotein B (gB) gene. DNA probes were labeled 
w ith DIG-dNTP using the random primed method, and hybridization was 
visualized by chemiluminescent detection using the Boehringer Mannheim 
Genius System. Sizes o f the RNA transcripts are indicated in  kilobase (kb) 
pairs. In  a ll blots, 5 pg o f total RNA was electrophoresed per lane.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
M WT RV6 RV7 M WT RV6 RV7
IE -  2.75 kb
IC -21 N IH3T3
M WT RV6 RV7 M WT RV6 RV7
IC -21 N IH3T3
M WT RV6 RV7 M WT RV6 RV7
L
-  3.3 kb
IC -21 N IH3T3
118
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
FIGURE 11. In  vitro analysis o f RV7 entry into fibroblasts and macrophages. 
Duplicate tissue culture plates were seeded w ith  2 X 106 NIH3T3 fibroblasts or 
IC-21 macrophages. The following day, the cultures were mock-infected (M), or 
were infected w ith w ild-type (WT) virus or the indicated recombinant virus (RV) 
a t a m ultip lic ity of 4 plaque-forming un its (PFU) per cell. A t 3 hours post­
infection, RNA was harvested from one culture for Northern blot analysis, and 
DNA was harvested from the other culture for Southern b lo t analysis. For the 
Southern blot, infected cell DNAs were digested w ith  Hind III, 10 pg o f digested 
DNA was electrophoresed per lane, and the blot was hybridized to a probe o f the 
MCMV Hind III-L  fragment. For the Northern blot, 5 pg o f tota l RNA was 
electrophoresed per lane, and the b lo t was also hybridized to a probe o f Hind 
III-L . Sizes of the MCMV Hind III-L  fragment and the IE1 RNA transcript are 
indicated in kilobase (kb) pairs.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
SOUTHERN
M WT RV6 RV7 M WT RV6 RV7
NIH3T3
NORTHERN
M WT RV6 RV7 M WT RV6 RV7
NIH3T3
119












FIGURE 1 2 . Effects o f MCMV m utants on the expression o f MHC class I. WT-19 fibroblasts were mock-infected (M), or 
were infected w ith  w ild-type (WT) v irus o r the indicated recom binant virus (RV) a t a m u ltip lic ity  o f 2 plaque-form ing 
un its (PFU) per cell fo r 24 hours. Cells were pulsed w ith  50 U /m l o f gamma interferon fo r 24 hours p rio r to infection. 
Cell lysates were prepared and precleared overnight w ith  mouse IgG. The H-2Kb class I heavy chain was detected by 
Western b lo t using the ECL method (Amersham Life Science) w ith  anti-peptide 8 (rabbit IgG served as a negative 






















FIGURE 1 3 . Growth o f MCMV m utants in  the salivary glands o f infected mice. Three-week-old BALB/c.ByJ mice were 
inoculated w ith  1.5 X 105 plaque-form ing un its  (PFU) o f w ild-type (WT) virus or the indicated recom binant virus (RV) by 
intraperitoneal injection. (A) A t 3, 7, 10, and 14 days post-inoculation, mice were sacrificed and the ir subm axillary 
salivary glands were harvested. The organs were ind iv idua lly  weighed, and a 20% (weight/volume) homogenate was 
prepared and titered on NIH3T3 cells by standard plaque assay. Each datum  po in t represents the average o f 3 anim als, 
and the standard deviation o f the geometric mean is indicated by the error bars. (B) A t 2, 4, and 6 weeks post­
inoculation, the salivary glands from  3 to 4 anim als were pooled, homogenized, and titered. The m inim um  level o f 
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FIGURE 14. Growth o f MCMV m utants in  the footpads o f infected mice. Eight-week-old BALB/c.ByJ mice were 
anesthetized and injected subcutaneously w ith  1.5 X 105 plaque-form ing un its  (PFU) o f w ild-type (WT) virus or the 
indicated recom binant v irus (RV) in  each h ind footpad. A t 4 days post-inoculation, mice were sacrificed and the ir 
footpad tissue was removed. A 10% (weight/volume) homogenate was prepared and titered on NIH3T3 cells by 
standard plaque assay. Each colum n represents the pooled footpads from  2 anim als. The m inim um  level o f detection 
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FIGURE 15. Transcripts and ORFs encoded w ith in  MCMV H ind III-J . (A) The MCMV H ind III-J  fragm ent, showing 
restriction  sites fo r H ind III (H) and Sst I (S). (B) RNA transcrip ts encoded w ith in  the H ind III-J  region. E designates 
early transcrip ts, L designates late transcrip ts, and num bers indicate the sizes o f the transcrip ts in  kilobase (kb) pairs. 
The arrows indicate the d irection o f transcrip tion . The s ta rt sites o f the E 4.1, 6.0, and 7.4 kb transcrip ts lie in  the 
adjacent H ind III-I region (indicated by the dashed line). (C) Arrangement o f the predicted open reading frames (ORFs) 
encoded w ith in  the H ind III-J  fragment. The positions o f putative TATA boxes fo r leftward-oriented promoters are 
indicated by the leftw ard-pointing arrows. The positions o f potential polyadenylation signals are indicated by the 
vertica l arrows. (This data was taken from  V ieira et a l., Journa l o f Virology, 68:4837-4846, 1994.) (D) Locations o f the 
RV5 insertion m utation (indicated by the vertica l arrow) and the RV6 and RV7 deletion m utations (indicated by the 






































































FIGURE 16. Trancrip ts and potentia l ORFs encoded w ith in  MCMV H ind III-I. (A) The MCMV H ind III- I fragment, 
showing restric tion  sites fo r H ind III (H) and Sst I. (B) RNA transcrip ts in itia tin g  w ith in  H ind III- I and term inating 
w ith in  the adjacent H ind III-J  fragm ent (indicated by the dashed lines). E  designates early transcrip ts, and num bers 
indicate the sizes o f the transcrip ts in  kilobase (kb) pairs. The arrows indicate the direction o f transcrip tion . (C) 
Arrangement o f the predicted open reading frames (ORFs) encoded w ith in  the H ind III-I fragm ent (which are oriented in  
the leftward d irection on the MCMV genome). (D) Locations o f the RV7 and RV9 deletion m utations, indicated by the 
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